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CHAPTER I 
INTRODUCTION 
The pharmaoologioal properties ot the ohemiaally 
homogenous group ot phenothiazine oompounds d1tter w1dely. 
Phenothiazine (tig. 1), the parent compound possessing the basio 
struoture of this group, had been synthesized in 1883 and had 
been introduoed as an entihelmintio primarily in veterinary 
medioine about 19)). Its olinloal use in man has been restrio-
tive beaause of its hemolytic aotion. fhe phenothiazines re-
oeived renewed interest as therapeutio agents within the past 
two decades trom two separate researah groups. In the United 
states the searoh for more potent antimalarials during World War 
II led to the synthesis ot various homologs ot phenothiazine 
(1-). fbe lO-dialkylaminoalkl1 phenothiaZine., the alosely 
related homologa of chlorpromazine (OPZ). were first synthe-
sized in 1944 by Gilman and ooworkers (1.2). The pharmaoologiaal 
properties of these compounds were not inve.tigated .inoe the •• 
phenothiazine derivatives failed to satiary tbe antimalarial 
interests of the.e researchers. Independently. the seaond group. 
headed by Halpern in Franoe, interested in the phenothiazines 
as drugs exhIbiting potent ant1b1stam1n10 act1vity with lesser 
~ 
slde ertects or toxioity than the known antlhistaminios, also 
synthesized 80me lO-dialkylaminoalkyl phenothiazines (4.5). 
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Figure 1 
Structural Formulae of Phenothiazine, 
Promethazine and Chlorpromazine 
Phenothiazine 
cx:X) 
I ",CH 
CH2 -?H-N'CH: 
CH 3 
Promethazine 
(Phenergan) 
Chlorpromazine 
(Thorazine, Largactil, etc., see text) 
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The.e derivatives, tor example, promethazine (phenargan, tig. 1) 
were round superior to the other known antihistaminic drugs. 
During the olinioal trials of the antlhistaminl0 
phenothiazine derivative., tor example, promethazine, marked 
hypnotio aftects were noted. Halpern et al. (6) reporting on 
the 100al anesthetio action of various antihistamine drugs ob-
served that oertain of the phenothiazine derivatives exhibited 
a distinotive type ot oentral aotion. Winter also reoognized a 
·oentral" oomponent ot aotion ot a pkenothlazlne oompound. pro-
methaZine, trom his study ot drugs causing tha potentiation of 
hexobarbital sleeping time in mioe (1) and the depression ot 
the oonditioned retlex in rat. (8). 
A ahemioal oongener of promethazine which would exhibit 
more potent oentral a.ction was sought. It was during this searoh 
that the syntheSis of lO-()-dimeth1laminopropyl)-2-ohloropheno-
thiazine (R.P. 4560) was aooomplished in 19,0 at Rhone·Pouleno 
Speoia Researoh taboratorien and reported by Charpentier et al. 
~ . 
(9) in 19$2. The generio name of ohlorpromazine (CPZ) was 
proposed by the Frenoh group (9). Prior to the publioation ot 
the synthesis ot CPZ by Charpentier studies ot the'pharmaoo-
logioal properties had been in progress (10) and reports ot 
c11nical trials of R.P. 4$60 had b.en published (11-16). The 
drug had been introduoed (11) by various trade names 1n different 
countries, tor example, Thorazine (United states), Largaotil 
(France, England, and Canada), Megaphen (Germany), Hibernal 
(Sweden), A.pliotil (Brazil), AMiniazine (Russia), and 
Ampllaotil (Argentina). 
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Courvoisier et ale (10) reported in detail on the 
pharmaoodynamic properties of R.P. 4560 (GPZ), a new compound 
utilizable to potentiate anestheslaand artifioial hibernation. 
Promethazine and CPZ were used in Europe a8 components for the 
"oooktail lytiqu.", a mixture used for the produotion of artifi-
cial h1bernation during surgery. This mixture usually consisted 
of an analgesio, a parasyapatholytic, an antihistaminic, and a 
hypothermio agent, and was administered as a pre-anesthetio 
preparation. Promethazine and OPZ were used in the preparation 
to produce the latter two eftects. Courvols1er and her assool~ 
ates demonstrated ~hat CPZ enhanoed the aotion ot general 
anesthetics, analgesios, and narcotic drugs, and exhibited 
sympatholytic, spasmolytic, hypotenslve, hypothermic, sedative, 
hypnotio, antioonvulsant, anti-emetio, antItlbr1l1atory and 
analeptio aotivities. Tne drug was oapable of exerting a de. 
pressive aotion on the oonditioned reflex aotivity and of aup-
pressing the psyohomotor activity ot the alcoholio, it reduoed 
oapillary permeability, exerted soa. proteotive aotion against 
hemorrhagio and traumatic shook} and it prevented blood ooagula-
tion. but at a oonoentration not attained in therapy; OPZ was 
found to be praotioally devo1dof antihistaminic aotivity. How-
.v~r, CPZ was introduoed into medioine as an antiemetia and 
preanesthetic agent. 
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In addition to the introduction of CPZ as a useful 
potent anti-emetio agent (18,19) capable of blocking the aotion 
or apomorphine on the ohemoreoeptive emetio trigger zone (20-22), 
and as an agent useful in the potentiation of anesthetios (15, 
23, 24) analgesios (25,26), and hypnotios (15), early olinioal 
reports (13, 16, 27, 28) made it evident that CPZ exerted a non-
hypnotio'depressant aotion on the oentral nervous system. 
Animals given OPZ displayed a oalming or dooilizing errect; they 
beoame lethargio and motionless (10). Thus, the usefulness 01' 
CPZ in alleviating anxiety, agitation and hyperaotive motor 
states in psyohotic and psyohoneurotic individuals beoame appar-
ent. Patients suttering trom simple or neurotio depressions and 
oertain melanoholias responded well to CPZ treatment (28). The 
anxiety and tension 01' neurotios were reduoed (21-30). Agitated 
behavior was oalmed without the produotion ot naroosis. ~. 
observed oalmness experienced diffe:red troll that following the 
use 01' sedatives. The somnolent patient could readily be 
aroused without exhibiting the stuporous state usually displayed 
by sedatives. A new term was in'i;roduo6.ito desoribe the pharma-
oologioal aotion 01' OPZ --Htranquilization", and the era 01' 
tranquilizers was introduoed with the advent of OPZ. !be 
introduotion of OPZ as a useful agent in this field of medioine 
has done muoh to revolutionize conoepts of mental health. The 
usefulness of CPZ as an anti-emetia and preanesthetic agent was 
overshadowed by its greater usefulne.s in psyohiatry. 
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The effeotiveness of CPZ in it. applioation 1n psy-
ohiatry was reviewed by Viaud (31) in 1954, leas than two years 
followIng the report of the synthesis of this compound. Sinoe 
that ti •• the literature pertaining to the applioation of CPZ 
in mental health and psyohiatrio treatment grew oontinually and 
Is, at present, voluminous. The Crug has found ~pplio~tion in 
the treatment of severe agitation, aoute and ohronic sohiaophre-
nia, manic states, depression, where anxiety and agitation pre-
dominate, psyohoneuroses and psychosomatio disorders, addiotion 
to alooholio and narootio drugs, and delusional, belligerant and 
anxiety reaotions in organio mental disorders (32). OPZ has been 
used suooessfully as an antiemetio and a pre-anesthetio agent. 
Several review artioles pertaining to the pharmaoolog-
ioal and tranquilizing actions of CPZ are available (33-38). A 
rather thorough comprehensive review, oontaining 6800 referenoes, 
on the ohemistry and pharmaoology ot CPZ and related phenothia.-
zine tranquiliaers was presented reoently by Soilenker and Herbat 
()8). Killam and Killam ()4,35) oite the ava1lable ev1dence 
indioating the involvement ot tha retioular system as a site for 
OPZ action. Domino (33) reviewed the data on th~ mode and sites 
ot CPZ action. Involvement of the hypothalamus and limbic system 
in the aotion of OPZ has also been indioated. Considering the 
multifaoet pharmaoological responses produoed by CPZ administra-
tion, it a.ppears that the meohanism ot aotion of CPZ may be 
oomplex. 
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Tissue distribution of CPZ following ita administration 
in vivo has been reported for dogs (39;40), mioe (41), rabbits 
(40), rats <40,42), and monkeys (42). However, there a;J,ears to 
be a laok of agreement among these investigators as to the dis-
tribution of CPZ within the tissues, particularly as to its 
localization within the brain. WeohslGr and Roisin (42) stated 
that after the administration ot massive doses (100 miorogm. per 
gm.) of CPZ, only traces of this oompound could be found in the 
brain. Low oonoentrations ot 835 CPZ in brain were also reported 
by Fyodorov (40), whereas Salzman and Brodie (39) reported that 
CPZ aocumulates in the brain. Their findings essentially agreed 
with those of Christensen and Wase (41). other differences exist 
between that data obtained by Salzman and Brodie and those 
obtained by Yasuda and Aoki (43). 
Methods have appeared in the literature pertaining to 
the chemical analysis ot CPZ trom biological fluids (44-47) and 
trom tissues ()9,48). The prooedures describing the quantitative 
determination ot CPZ in biological tissues present oertain dis-
advantages. Salzman and Brodie's procedure ()9), based on an 
extraotion ot CPZ from an alkalinized biologioal solution into an 
isoamyl aloohol-heptane mixture, and subsequent re-extraction 
into dilute hydroohloric aoid, requires an ultraviolet speotro-
photometer tor the determination of CPZ. Thus, a correction for 
tissue blanks is neoessary because the blanks read high in the 
ultraviolet light. Moreover, they report that by their method, 
8 
only 40% ot OPZ was reoovered after the addition ot the drug to 
brain homogenate. Weohsler and Forrest (48) modified the 
Salzman and Brodie method; they ohanged the oomposition of the 
organic extraotion mixture. substituted glacial aoetio acid tor 
the hydroohlorio aoid. and added hydrogen peroxide. They olaimed 
95% OPZ recoveries trom brain tissue. However, utilizing the 
modified prooedure, Wechsler and Roizin (42) reported very low 
oonoentrations ot OPZ in the brains of monkeys and rats following 
massive doses of the drug. The data of Weohsler and Roizin 
suggest that their reo overy of CPZ trom tissues. in vivo, was 
incomplete. 
CHAPTER II 
PtffiPOSES AND APPROACHES TO THE PROBLEM 
The methods available for CPZ analysis from biologioal 
tissues appear inadequate, primarily beoause of insuffioient 
reoovery and of the neoessity of oorreotions for the high tissue 
blanks. One of the purposes of the researoh desoribed here is 
to present a ohemioal prooedure whioh oan eliminate these inoon-
venienoes. 
The ohemioal prooedure based upon the oxidation of CPZ 
with sulfurio acid, previously desoribed by Duboat and Pascal 
(44) for the determination of OPZ in biological fluids, oonsti-
tuted the basis for the present method. However, the oxidation 
was performed in the presence of ferrio ion. ~lis prooedure 
provided the advantages of obtaining speotrophotometrio readings 
in the visible range and eliminating the necessity of oorreoting 
for tissue blanks and for inadequate reooveries.. The average 
reoovery of CPZ added to brain homogenates was about 90%. 
Drugs are usually distributed throughout the body onoe 
they are administered into the system. Certain tissues oan 
exhibit definite affinities for that oompound and can accumulate 
the drug either in high or signifioant oonoentrations. Informa-
tion about the distribution at a particular drug may provide 
some inSight pertaining to the site of aotion for that drug. 
Often the localization of the drug in an organ or tissue may be 
Q 
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assooiated with the ooncept of the target site of action, that 
Is, the organ oharaoterized by high oonoentrations ot drug Is, 
at the same time, responsible for the pharmaoological etreot. 
Th. accumulation of iodine in the thyroid gland tor the treat-
ment of goiter (49) may be oited as an example. Conoentration 
of a drug in a particular tissue is not always a necessary cri-
terion for the site or drug action. A drug may oonoentrate in 
large amounts in some organs or tissues and produoe no the~apeu­
tic or pharmaoological activity. ~he deposition of high ooncen-
trations of thiopental in the rat, is marked even after the 
animal haa recovered from the hypnotio .treot of the drug (50-52), 
It becomea apparent then that the fat serves as storage sites 
rather than the site ot aotion. Dig1talis, a drug whoae eftect 
1s dil~aotly on the I'IJ.yocardiulJ3, also does not seleotively 
looal1ze in heart musole (49). 
Pharmaoologic eftect of a drug may often be related to 
its conoentration in plasma (52-54) as ,iell as to its deposition 
or aCCUMulation in the tissues. That o?th these faotors playa 
role 1n drug action would be little disputed. Brodie et al. 
(SO,51) interpreted the deposition of thiopental into body fat 
8S being related to the termination of its anesthetio aotivity. 
Almost a deoade later, Goldstein and Aronow (S2) extended the 
earlier experiments and showed that the terMin~tion of thi0pental 
aotlvity could be more oorreotly assooiated with 8. oritiaa,l 
conoentration presented in the 8,l""eas of the brain affeoted. 
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In this oonsideration, the question arises whether 
the drug aotion is assooiated with the target organ or with a 
reoeptor site or sites on that particular organ. That is, a 
drug ~ay be seleotive in its action. It may affeot a speoific 
tissue or a speoifio site on that tissue, perhaps a sinp,le oell 
O~ group ot oells which are highly specialized or sensitive to 
that partioular drug. These may be considered as reoeptor oells. 
Furtherll1ore, the sensi ti vity of that reoeptor oel1 or group ot 
oells to the drug may be limited to a small area looated on the 
surtace or the interior ot the oell, that is"same specitio site 
ot the cell. Sinoe ~.J. Clark tocused attention upon the impor-
tance of the molecular organization of the cell, present conoepts 
imply that moleoules of compounds, or drugs, do not reaot with 
the oell as a whole, but with other molecule. of whioh the cell 
may be composed or whioh it oontains. These cellular moleoular 
aomponents become ot importanoe onoe the site of aotion tor that 
particular drug is determined. 
Distribution stUdies often help provide some indioatien 
of the drug aotivity. It not trom the aspeot ot site ot aotion, 
these stUdies may provide the necessary information of absorption, 
storage, metabolism, exoretion patterns, toxioit7, usefulness in 
therapy. and perhaps dosage requirements 1n relation to effeots. 
Sinoe the reports ot tissue distribution ot OPZ 
following its adm1nistration to animals appear inoonolusive, it 
was of interest to study tissue distribution ot OPZ in oats. In 
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view ot the pauc1ty ot data on the fate ot CPZ in animal tissues, 
its distribution was traced for forty-e1ght hours atter its 
adm1nistr~tion. Ce~tain behavioral and pharmaoologic observations 
were correlated with tissue levels of CPZ. 
From the observ8~~1ons obtained in vivo, it was consid-
ered interesting to study whether significant uptake ot CPZ by 
the tissue can occur in vitro. Many methods (54-56) are avail-
able for studying protein interaction with relatively small ions. 
such as drugs. Goldstein (54) classified the teohniques employed< 
in vitro under three basio prinoiples: 1) Thoae prooesses whioh 
study protein interactions based upon the reduotion of the 
thermodynamio aotivity of the drug whereby the conoentration and 
the biologioal aotion of the drug may be reduoe4; 2} Those proo-" 
esse. whioh measure alteration of drug propertie., for example. 
solubility. diffusion. stabilization. Reduction of thePmod,namio 
aotivity may also explain some of these effeats, and 3) Tho •• 
processes whioh ()bserve changes in the properties and behav10r 
of the protein. 
The first two principles, thus, deal with teohnique. 
which involve changes in the interaoting moleoule, that is, the 
drug. Equilibrium dialysis, an sxample of the first group, 
r.sult~ in a reduotion in thermodynamic activity ot the smaller 
moleC'ule. Osborne (57). almost s'\.xty years ago, demonstrated 
the usefulness of this teohniQue for protein interaot'ons with 
salts. The applioation of the equilibrium dialysis teohnique to 
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the study of organio ions was made by Klotz, Walker, and Pivan 
(58) who reported on the binding ot sulfonate anions ot methyl 
orange and azosulfathlazole by bovine serum albumin. Sinoa then, 
many slgnificant equilibrium dialysis studies with organio oom-
pounds ha.ve been reported (54,59-64). Most of the investigations 
utilizing thia technique have. been on purif1e. proteins, tor 
example, bovine serum a.lbum.ln and globulin. 
The equl11blium dialysis teohnique in the following 
experiments was performed with OPZ dialyzed alainst the tissue 
homogenate. !he primary purpose of the study utilizing tn. 
equilibrium dialysis prooedures was to determine whether inter-
aotion ot CPZ with tissue homogenate. can ooour and whether yari-
ous tissues in this system would exhibit difterenoes in uptake 
of CPZ somewhat similar to that observed in vivo. Thus oompeti-
tion by the tissues for the upt~e of CPZ in vitro was investi-
gated. Some preliminary experiments pertaining to the strength, 
or affinity, of the tissue binding of OPZ were made. 
Inte~aations ot small moleaule., for e~ample. druga, 
with maoromoleoules, the oellular constituents, are ot interest 
in pharmacology from the standpoint ot drug aotion, storage, 
metaboliuM, exoretion, and transport. Of the man7 available 
methods tor studying smdll ion interaotion with proteins, in 
vitro, the equilibrium dialysis teohnique vas .eleoted because it 
is felt that the results obtained by this teohnique may be used 
to provide some information for the .eohartism of CPZ aotioQ. 
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These results a,. be oonsidered prel.iminary work toward the oon-
sideratlons ot CPZ aotion at the moleoular and possibly the 
"reoeptor" level. Investigations ot the oharacterIzation of the 
oellular oomponent or oomponents involved in the interaotion with 
CPZ were not pursued in the present work. 
Pro. the applioation of the law of mass aotion to the 
multiple equilIbria involved in lan-protein Inte~aotion8, results 
obtained trom the equilIbrium dialysis teohnique emplOying purl-
fied proteins oan be extended for the oalculation ot the energy 
ot assooiation ot eaoh suooessive ion to a protein as well as to 
the number ot sites available for the binding ot the ion ($$). 
While this applioation Is beyond ~he soope of the present exper1-
.ents, 1t would inde.d be ot interest tor a future investigation. 
CHAPTER III 
MATERIALS AND METHODS 
Prinoiple ~ ~ ChlorEromazine Method 
The ohemiaal prooedure based upon the oxidation of CPZ 
with sulfurio aoid, previously desoribed by Dubost and Pasoal 
(44) for the determination ot CPZ in biologioal fluids, oonsti-
tuted the basis for the present method. However, the oxidation 
was performed in the presenoe of terrio ion. This prooedure 
provided the advantage ot obtaining results trom speotrophoto-
metrio readings in the visible range. 
CPZ was extraoted by diethyl ether ira. alkalinized 
solutions ot tissue homogenates or ot Whole blood. The drug was 
then extraoted trom the ether into 2M sulfurio aoid. An aliquot 
of this aqueous layer. to whioh ferrio ion had been added was 
mixed with an equal volume of oonoentrated sulturio aoid to pro-
duoe a oherry-red oolor whioh showed an absorption maximum 
between $20 and S30 m~(Fig. 2) in the Beckman B speotrophoto-
meter. Maximum absorption in the ultraviolet range at about 
275 .~ia shown in figure ). 
The intensity of color read at 5)0 m~depend.d upon the 
oonoentration of sulfurio aoid and of terrio ion. Figure 4 
denotes the relation between sulfurio acid oonoentration and 
color development at two Qonoentrations of CPZ. In the absence 
of terric ion, little oolor was produoed even at 30 m1orogm./ml 
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Figure 2: Upper Half. Absorption speotrum in visible range for 
ohlorpromazine. Absoissa, wavelength (A) in~. Ordinate: 
optical density (O.D.). Beokman B speotrophotometer was employed 
Chlorpromazine oonoentration, 20 miorogm. per ml. 
Figure 3: Lower Half. Absorption speotrum in ultraviolet range 
tor ohlorpromazine. Absoissa: wavelength ().) in~. Ordinate: 
optioal density (O.D.). Beokman DU speotrophotometer was em-
ployed. Chlorproma?ine oonoentration, 10 miorogm./ml. 
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Figure 4: Effeot ot sulfurio aoid concentration upon color re-
aotion of chlorpromazine in presenoe and in absenoe of ferric 
ion. Solid lines represent oolor development in presence of 
ferrio ion, broken lines refer to oolor development in abseno. 
of ferrio ion. Circles and triangles denote 20 and 30 miorogm. 
per ml., respeotively, of ohlorpromazine. Absoissa: molarity of 
tinal sulfurio a01d oonoentration. Ordinate: optioal density 
at $)0 ~. 
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ot CPZ in the tinal reaotion mixture, and the difterenoe in opti-
oal density between 20 and 30 miorogm./ml ot CPZ vas insuffioient 
to lend itself for an analytioal prooedure. In the presenoe ot 
terrio amD&onium sulfate (200 miorogm./ml), intense oolor was 
produoed by stronger (trom 4 to 9 M) oonoentrations of sulfurio 
aoid; oolor intensity seemed to approaoh a pl1teau with 8-9 M 
oonoentrations of sulfurio aoid. Figure 4 also shows the de-
pendenoe of the oolor upon terric ion in the presenoe of sulfurio 
aoid. 
Pigure 5 shows the erteot on oolor development when 
ferrio ion oonoentration was varied and the oonoentration ot CPZ 
vas 20 miorogm./ml in the final reaotion mixture. In the absenoe 
of sulturio a01d, the oolor was slight even when oonoentrations 
ot terrio ammonium sulfate were aa great as 1000 miorogm./ml. 
Furthermore, the color was unstable, and it faded to a turbid 
orange within ten minutes. The presenoe of sulfuric aoid 
(Fig. 5) both intensified and stabilized the oolor. 
Thus terrio ion alone, or sulfurio acid in the absen.e 
ot ferrio ion, were not satisfaotory for quantitative analysis or 
CPZ. For conoentrations ot ferric ion and sulfurio aold emplo'1ed 
In the prooedure, the relationship between CPZ ooncentration and 
optical densit'1 followed Beer-Lambert'. Law over the oonoentra-
tion range of from 1 to 35 miorogm./ml of OPZ (Fig. 6~. 
Oxidation to the red ohromophore did not ooour with 
the ouprio, mercurio. zino, molybdate, cobaltio, manganio, or 
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Pigure 5: Oxidation of chlorpromazine by ferric ion in the 
presence of sulfuric acid. The two curves refer to oolor davel-
opment with inoreasing oonoentrations ot ferric ion in 4.5 and 
9 M H2S04. Each point represents: one experiment. duplicate 
readings, 1n the case of 4.5 M H2S04; two experiments with dupli-
oate readings in ,the oase ot 9 M H2S04 (vertical bars represent 
range of optioal densities). Absc1ssa. mM Pet++. Ordinate: 
optical density at 530 ~. 
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Figure 6: Oxida.tion of ohlorpromazine to a oherry-oolor ohromo-
phore in the presenoe of sulfurio acid and ferrio ion. Absoissa: 
oonoentration of chlorpromazine, miorogm. per rol. Ordinate: 
optioal density at 530 trlft-e From two to four experiments per 
ohlorpromazine oonoentration indioated; eaoh experimental point 
represents duplioate readings. 
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ohromio ions, nor did it occur when the ferrio ion was oomplexed 
as in ferrloyanid. or ferrooyanide. The oeric ion, however, was 
found as effeotive as the ferric 10n (65). 
Detez:mina tion 2! .Q!.! .!n Blood .!!!.<! .... O ... t.;.;;h .... e... !" Tissues 
Homogenate. of brain, liver, muscle and other tissues 
were prepared in a ratio of 1.0 gm of tissue to 2.0 ml water. 
Whole blood, 01"1.0 ml of whole blood diluted with water to 3.0 
ml, was used. To 3 ml of the homogenate or of the blood sample, 
20 ml of anhydrous diethyl ether was added, tollowed by 2 ml at 
.$ N sodium hydroxide. The mixture, in a tightly stoppered bottle 
was shaken meohanioally tor thirty minutes. The aqueous layer 
was disoarded and the ether layer was washed onoe with S.O ml ot 
water. CPZ was then extraoted from the ether by shaking for 
sixty seoonds with three separate portions of 3.0 ml of 2 N <4 M) 
sulfurio anid. The traoes of ether trapped in sulfurio aold 
were removed overnight in an air oven at 50-55 0 C. Subsequently, 
0.2 ml of 2 per oent (0.0415 M) ferrio ammonium Bultate was 
added, the volume adjusted to 10 ml with 0.1 N (0.2 M) sulfurio 
aoid, and a 5.0 ml aliquot of this solution was mixed with an 
equal volume of oonoentrated sulfurio a01d oooled in an ice bath. 
After reooo11ng, the mixture was permitted to equilibrate for 
thirty minute. in the dark at room temperature and then read at 
530 ~ in the Beokman Model B Speotrophotometer. A blank, oon-
sisting of 3.0 ml of distilled water, as well as standard aolu-
tioDa oontainin or 200 m1oro~m. of 
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were carried through the entire procedure. 
Methods Employed ~ Animal Procedures 
Fresh aqueous 2 per oent solutions ot OPZ hydroohloride 
were employed for the intravenous injeotion tnto the saphenous 
or temoral vein of adult cats. The doses were 40 miorogm. per 
gm. (30 oats) and 20 miorogm. per gm. (2 cats). 
Rapid intravenous injeotion ot 40 miorogm. per gm. ot 
CPZ is usually tatal within two minutes. Slow and rapid adminis-
tration was, therefore, employed to determine tissue levels of 
CPZ after prolonged time intervals and immediately after its ad-
ministration, respectively. In the former oase, injeotion inter-
vals ot five to fifteen minutes were used. Tissue levels' of OPZ 
were determined at intervals timed from the start of the injeo-
tion until the animal was saorifioed by intravenous injeotion of 
air (27 cats). Tissue samples were then removed as rapidly as 
possible. Blood levels of CPZ were determined immediately, other 
tissues were frozen on dry ioe, and stored until analyzed. 
To ·determine CPZ oonoentrations in whole blood and in 
other tissues immediately following its administration, poly-
ethylene cannulae were inserted at least one week before CPZ in-
jeotion. Cannulae, inserted while the animals were under ether 
anesthesia. were plaoed into the right femoral vein for rapid 
(15 seoond) injeotion of CPZ and into the left femoral artery for 
rapid withdrawals of blood (3 cats). All blood samples were 
oolleoted 1n he arinized s in~es. 
2S 
Reotal temperature, reaction to pain, righting reflex, 
pupillary diameter, and the nictitating membrane were observed 
in seventeen animals. In the oourse of preliminary experiments 
on the hypothermic aotion of OPZ, it was notioed that immobiliza-
tion resulted in a fall in body temperature even in unmedioated 
animals. 'ro distinguish between the hypothermic B.otions oaused 
by the drug and by immobilization, the following prooedure was 
employed: tive oats were restrained in a supine position for 
two to twenty~rour hours, and their reota1 temperatures measured. 
After permitting at least tour days tor reoovery, CPZ was admin-
istered (40 miorogm. per gm., Intravenously), the oats were re-
strained again for various time intervals, and reotal tempera-
tures were reoorded hourly for forty-eight hours. Analgesia was 
measured by observing the reaotion of the oat to pain produoed by 
applying a hemostat clamp on the tailor the toe pad for fifteen 
seoonds. 
Prinoinle of Equilibrium Dialysis 
In essenoe, in the equilibrium dielysis technique, two 
oompartments are established by the presenoe of a membrane, per-
meable to smaller ions but impermeable to larger molecules such 
as proteins and various struotural oell components. Tissue 
homogenates, prepared in a suitable burfer, oonstituted the inner 
oompartment; known conoentrations or CPZ in the same butfer were 
in the outer compartment. Several varIants of this basic proce-
dure are described bel w 
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whioh the penetration of CPZ through the membrane may OOQur, 
aliquots were analyzed for CPZ content. Interaction of CPZ with 
oellular oomponents ot the tissue homogenate may be oonsidered 
to have ooourred 1t. at equilibrium, the amount of CPZ per unit 
volume lound in the inner ohamber was greater than the ooncentra-
tion of CPZ in the outer chamber. However, if OPZ ooncentrAtions 
in both chambers, at equilibrium, were approximately equal. it 
mar be assunu'td that interaotion of OPZ wi th oellular oomponents 
was negligible. 
Two inherent souroes of errox- in the equilibrium di-
alys18 method have been reoognized (55). For one, there ma,. be 
asymmetry in the distribution ot the small molecule. if tt is 
ionio, as a oonsequenoe ot th. Donnan membrane ertect. Either 
oorreotions can be employed to lninim1ze any disorepanoies in 
distribution due to the Donnan effect, or it oan be reduoed to 
negligible proportions by the addition of an innoouous eleotro-
lyte (66). The assymmetrio distribution of the small ions dUIB 
to the Donnan efflBot may also be eliatnated if the p~ selected i. 
at the isoel.atria point. In the present experiments, the phos-
phate bufte%' was aonsidered as provid.ing an inno(}uouS eleotro-
lyte. Seoondly, absorption ot the small molecule (CPZ) to the 
membrane may oocur. Correotion or possibly el~"minAtion of this 
souroe ot error oan be made by employing II. oontrol dialysis, In 
whioh the butter solution replaced the homogenate in the inner 
chamber and CPZ 1s measured in both oompartments. This prooedure 
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was adapted in these. experiments. 
For meaningful .q~ilibrium d1a17sis results, the vol-
ume. of the two cbambers should remain oonstant. Osmotio pres-
sure ettects may arteat the experimental results obtained tr~ 
equilibrium dialysis by oausing shitts in the volume of water 
between the two oompartments. Low conoentrations of homogenate 
or of the test drug tend to minimize or eliminate osmotlo pres-
sure eftects. 'fo asoertain that osmotlopressure etreots did not 
enter as a variable during these experiments, volume measurement. 
or the Inner oompartment were performed periodioally. No signi-
fioant ohanges In volume of the Inner oompartments were observed 
with the oonoentrations of homogenate or of drug employed. 
So~utions EmPloyed ~ Equilibrium Dialysi. 
CPZ Stook Solut10ns 
--- ----- ---------
stock solut1ons of 500 mg. CPZ hydroohloride per 50 ml 
water were prepared and kept refrigerated in the dark unt11 u.ed. 
Aliquots were removed and 411uted with phosphate bufter on the 
da7 ot use. 
Thimerosal solution 
A oommeroial preparation ot tht'uerosal (Eli Lilly and 
00.), 1:1000 solution, was employed. 1 ml ot the stook solution 
was diluted to 10 ml with water. 0.5 ml of the thimerosal dilu-
tion was added to eaoh 30 ml ot butfered CPZ solution. 
Phosphate Buffer Solutions 
Fisher 
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soientifio, A.R. (Lot #120607), F.W. 141.965 was used. 9.48 gms. 
per liter of water was prepared as stook solutions. 
Potassium dihydrogen phosphate, KH2P04' Fiaher scien-
tIfic, A.R. (Lot 1722191). P.W. 1)6.091 was used. 9.08 sma. per 
liter ot water was prepared as stock solutions. 
Des1gnated proportions of' each were mixed to prepare th 
phosphate bufter employed in the experiments (s •• appendix). 
Preparation ~ ~i •• u. HONOaenate. 
The initial experiments were performed with the inner 
ohambers oontaining homogenate. prepared in a ratio ot 1.0 gm. ot 
tissue to 2.0 ml of phosphate bufter (that is, 1:3 tissue hoao-
genate. similar to that desoribed in the previous section for the 
anal'1.1s of tissue distribution of CP.Z in vivo). The 1: 3 homo-
genate dilution had b •• n •• leoted for the analysis ot tissues ob-
tained trom the oat which had been administered OPZ beoause ot 
oonvenienoe of volumes sinoe at instances CPZ might be present in 
oonoentrations insuffioient to be analyzod from less than 1 gm. 
ot tissue. This homogenate preparation, 1:3, was undesirable tor 
the dialysis procedure because the tissue was too conoentrated. 
Further~ra, the 1:3 homogenate preparation exhibited an uptake 
or CPZ during equilibrium dia.lysis Hhioh required high dilutions 
for the analysis of CPZ. The level of CPZ in the inner oompar·t. 
ment when homogenates of 1:10 or 1:100 tissue dilution were 
employed was at a suffioient oonoentration for oonvenient analysi8 
her.tore 
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utI1Izlng the tissue homogenates prepared as 1110 dl1u_ions (1 
gDh ot tissue plus 9.0 ml solution) or 1:100 dilutions in thf) 
phosphate butter used for that partioular experiment. Tbe prep-
aration of the latter dilution vas efreoted by diluting aliquots 
of the 1:10 tissue homogenate to the appropriate volume with the 
phosphate burfer. 
Boiled Homogenate 
Tissue homogenate (1:100) prepared as desoribed 9bove 
was plaoed on a hot water bath at 90 0 C for two hours. The tubes 
were covered with glass oondensation bulbs during this proaedure. 
After oooling to room temperature, suitable aliquots were pipet-
ted into the dialysis bag. 
AGed Tissu! Homog~nate 
Aged tissue refe.!'s to ti-ssue homogenate (1:100) whioh 
had been prepared as described ~bove, stored. in stoppered con-
tainers at 0-4 0 C for a period of two to four weeks. 
Preparation ~ ~ Dialysi. Tubina 
Por equilibrium dialysis, the membrane should be per-
meao16 to water and the drug under inVestigation, and impermeable 
to the binding substance suab as, the protein, or, in this in~ 
stan •• , the non-diffusible aonstituents of the tissue bomogenate. 
Cellophane dialysis tubing appeared to be suitable. The tubing 
vas a s.~1.8e produot prepared trom regenerated aellulose by a 
vi8008e process. Beside oellulo •• , the manufaoturer atat •• that 
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the tubing "7 oontain gl7oe~1ne, wate. and traoe. ot sulfur 
oompounds (approximatel, 0.1 per oent). App~eQtl7 this small 
quantity ot sulfur left 1"1'oDl the manufaoture or the IUl~~in8 can 
interfere during binding studies of various metallio ions. In-
terterenoe in studies of protein oomplexes of some metals by the 
sulfur lett in the oasings has been reported (55). Therefore the 
r.soval 01' sul1"ur prior to the use ot the tub1n<~ i8 indioated. 
!he method suggested by Hughes and Klotz (55) tor the 
preparation of tubing for equilibrium dialysIs oonstituted uhe 
basic prooedure used in these e~p.rlments. Lengths of aouut ten 
inoh •• ot the oellophane cas ins were immersed in a beaker o'dIs-
tilled water, and. heated 1n a boiling water bs.th at 86 0 C for 
~5-60 minutesJ thE) strips were transterred to fresh d1.stI11ed 
water and the heating ",8r1od was repented. The strips were then 
transterred through several washings of distIlled water &~ room 
temperature and kept 1n distilled wat~r until ready tor use. A 
sutfioient number of strips were removed trom the distilled water 
and soaked overnight in the appropriate phosphate burter used tor 
the equilIbrium dialysis prooedure. 
Excess buffer was removed by pulling the strip between 
the .fingers three or tour times. A double knot was tied on one 
end and the tissue homogenate in the appropriate butter, or, when 
used tor controls, the butter solution alone was plpetted into 
the dialysis bag. The top was then t1ed Into a double knot, and 
the tips ot the bag were out close to the knots at both ends. A 
)1 
'ht-• .,d, peraa1'tlng tor ,,. •• 40. ot aot108 of the baa, was t184 '0 
one end 1n ord.r to facilitate easy removal ot tn. 41al,sl. bas 
fro. the te.t tube. 
D1all818 Proc.dure 
Th1rty ml a.liquots of the phospha',e buffered CPZ solu-
tion were pipettod into 40 ml polyethylene tubes. ~~1mero8al 
(0.5 m1 ot 1:10,000 solution) was added to elim1nate baaterial 
growth during the experimental interval. A dialysis bag oontain-
illg 10 ml ot the tissue homogenate prepared as desoribed above 
wal immersed into the CPZ solution. Paratilm layered beneath the 
rubber stopper was used to tightly stopper the tube. The inner 
coapartmont ot the aontrol assemblies oontained 10 ml ot butfer 
solution but no homogenate. Aliquots of both o,)mpartm.euts we,.,.. 
analyzed for CPZ. control dialysis assemblies were preparQQ to 
assure that sufficient time to attain equilibrium elapsed aDd to 
pro'9ide a oheck against errors due tf) absorption of GPZ onto the 
oellulose dialysis tubing. EquIlibrium. was determined by emplp7-
ing a sarles of similar chambers trom which at varying intervals 
samples were rem.oved for analys1s of OPZ. Thus, .qui11brlwa was 
ascertained when the conoentration of CP~ of the oham.bers ihowed 
DO further ohanges or for oontrol, CPZ conoentration in one lnner 
and outer chamber were approximately equal. 
Aooording to Hughes anei Klotz (5» adequate stirring 
should be maintained to hasten the equilibrIum time. M1xlt!g 
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method, a ugnetic stlrring bar was plaoe" In the outer .ompa.r1l-
l'Iu9nt,t:loD.eq,uently, the ti •• ue homogenate .ettled during the 
dialyai. prooedure. The question was rais.d that the settling 
of the homogenate may reduoe the surfaoe area of the tl •• ue oom-
ponents exposed to the CPZ moleoule. In the other teohnique 
theretoN, the Whole assembly was plaoed onto the Eberbaoh shak-
ing maohine. No se1ltling ot homogenate ooourred in this latter 
o as.. Both mixing prooedure. were performed so tha.t the tube. 
were enolosed in a darkened container in order to reduGe the pro-
duction of oxIdation produGts formed by OPZ trom exposure to 
light. 
At the <ie.ignated intervals whioh oonstltuted the oon-
olu.lon of the experiment for that partioular a •• embly, the di-
alys1a bag was removed and blotted dry with tis.ue paper. One 
end 01' the bag was out just below the knot: and the content. poured 
into a te.t tube. In the situations where settling of the homo-
senate ooourred, the bag was inverted several time. to assure 
adequate resuspenslon 01' tbe bomogenet. prior to removing the 
aliquot for analysis of CPZ. 
At the termination ot the experiment the pH or th. 
butter, the buttered CPZ solutions, and the solutions ot the 
outer compartment ot eaoh re.actlon mlxture were read on a Beckman 
ZeroDlatic pH Instrument. Changes in pH were not ob •• rved 1n anr 
reaotlon vessel even forty-elght hours atter the start ot the 
experiment. 
)) 
Three approaahe. of the equilibrium dialysis pro •• dura 
were designed to atudy the uptake, afflnlt1. and ao.petition 
between the tisau ••• 
1) For the meaaurement of uptake of CPZ, the prooedur. 
as desoribed above wal employed, that ls, OPZ in the outer solu-
tion was dialyzed against the tissue homog~nate. 
2) Similar experiments were performed using a single 
outer ohamber and two or more tissuea in separate dialysis bags 
to show whether oompetition for CPZ Hould oocur bet,>1een tissues. 
In these latter experimenta, the ratio of total homogenate vol-
umea in the inner oompartments 1;0 that of th e buftered CPZ volume 
in the ater oompartment was identioal with the ratio whioh ob-
tained in the measurement of uptake. For example, when four 
homogenates ot oerebrum, heart, liver, and lung, were used to 
obaerve whether oompetition would oocur between theae tlssue., 
8.0 ml of eaoh homogenate in separate d1alysis bags were suspend-
ed 1n 96 ml ot buttered CPZ solution, or 2.5 m1 homogenate. of 
eaoh tissue were suspended in 30 ml of solution. Henoe a oon-
.tanoy ot a 1.3 ratiO of inner to outer oompartment volume a wal 
maintained in the ayat.... In so.e 1nstanoes, only two tlasue. 
were employed for oompetltion experiments. Again the ltl ratio 
~t combined inner to outer ohamber volume was utilized. 
) For an Indloat1on of the attluity ot CPZ tor the 
tlssue, two experiments were oarried out.'; a) A d1alysis bag waa 
oarr1ed through the prooedure 1 tor uptake. After equilibriu., 
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the bag was removed, blotted dry with tissue paper, and trans-
ferred to a fresh ohamber oontaining only the bufter. Dialysis 
exoeeding the equilibriuM time period was repeated. b) A tissue 
with know CPZ oontent obtained from an animal administered OPZ. 
was dialyzed against the butter, and also against a butfered CPZ 
solution. 
CHAP'l'ER IV 
RESULTS 
Recoverz !! Chlorpromazine ~ Biological 1issues 
The extent ot reoovery ot aPZ inoubated with brain 
hOllOgenates wal lnvea tigated. CPz, 2.$0 11110rogll. (13 e:x.perilllents) 
and 25 miorogm. (8 experiments), was inoubated in 1.0 gm ot brain 
homogenate. The average reooveries were 81.6 ! 10.8 and 86.9.5 t 
6.51 per oent. respectively (Table 1). 
Speciflcitz ~ ~ Method 
Thls chemical procedure was reported in thls laboratory 
as being specitio for the intact molecule ot CPZ and its sulfox-
ide (67). More extensive studies of spe.ltiolty were oarried 
out at present. !he method proved speoifio for the intaot pheno-
tbiazine rlng with the ohlorlne atom In the number 2 positlon, 
and tor the corresponding sulfoxldes (Table 2). Alterationa in 
the 10-dimethylallinopropane side ohain did not alter the colored 
reaotlon produot. 1he method did not distlngulsh between CPZ, 
ohlorpromazine-X-oxide (CPZ-NO). seoondary (Norl GPZ, monomethyl-
ohlorpromazine) and prlmary amine (Nor2 CPZ) analogs ot CPZ, pro .... 
ohlorperazine, perphenazlne, and thiopropazate (Table 2). The 
earlier results (67) suggest that sulfoxide. ot the.e oompounds 
would reaot in a similar manner. 
Ab8o.ption spectra of several phenothiazine. were in-
vestigated over ultraviolet (Pi. 2,1) and visible (Figs. 8,9) 
Table I 
Reaoveries ot Chlorpromazine f,,-om B1'8.1n Homogenates 
(CPZ was added to bra1n homogena.tes 1:.3 for analysis) 
CPZ CPZ % Mean ~ 
added ,..eoovered* reo overed recovered (mlcrogm.) Calorogm.) ± S.D. 
250 225 90.0 
2$0 221 88.2 
2.$0 1.$9 6).8 
250 192 16.1 
2.$0 239 9$.9 
2$0 234 93.9 
2.$0 21$ 86.0 81.6 ± 10.8 
250 215 86.0 
2$0 236 94.$ 
250 262 105.6 
2$0 232 92.9 
250 229 91.5 
2$0 186 74.2 
2$ 20 80.0 
2S 18.75 75.0 
25 22.8 91.9 
25 21.1 84.5 86.9.$ t 6 • .$1 
25 22.8 91.1 
2.$ 22.2 89.0 
25 2.3.1 92.4 
25 2.3. 92.5 
*Value. are averages ot duplioate determinations 
T -\'BLE 2 COLOR FORMATION BY lO-SUBSTITUTED PHENOTHIAZINES AND RELATED COMPOUNDS IN PRESENCE 01 
H2SO, AND Fe+ +- + 
(XI Sx4~T R' 
"" N 19-
2 
I 
R 
__ -__ ~ ____ ~ E". values read at 10 to 20 microgm/ml. 
Drug R ----~R~1------.~C~o7w~r----~E~.~,.--~ 
C-h;-I;--o~rp~r~o~m~a~zl;--n-e (CHJ,NMe, ----~ ~ --~c1---C;o;-:-he~r~~~y-~re~d7 1-096 x 10' 
Chlorpromazine 2° Amine 
(SKF 4514 A, Nor, CPZ) (CH,),NHMe 2-CI Cherry-red 1-208 x 10' 
Chlorpromazine-N-oxide 
maleate 
SKF 6100 A 
Prochlorperazine 
Perphenazine 
Thiopropazate 
Chlorprothixenet 
Imipramine HCI' 
2-Hydroxypromazine maleate 
Methoxypromazine maleate 
Promazine 
Trifiupromazine 
Fluphenazine 
Thioridazine 
° (CH,),JMe, 
(CH,),NMe. 
/---', 
(CH,),N N- Me 
'x_/ 
/-~'x 
(CH,),N N(CH,),OH 
'x _~_/ 
/-'x 
2-C1 
2-CI 
2-CI 
2-CI 
Cherry-red I -092 x 10' 
Cherry-red I -079 x 10' 
Cherry-red 0 ·927 x 10' 
Cherry-red I 192 y 10' 
(CH,),N N(CH,),OCOMe 2-CI Cherry-red I -177 x 10' 
'x_~ j 
~CH(CH,),NMe, 
(CH,),NMe, 
(CH,),NMe, 
(CH,),NMe, 
(CH,),NMe, 
(CH,),NMe, 
/--'x 
(CH,),N N(CH,),OH 
'x_~/ 
(CH.).-(~--> 
N-~ 
.j. 
Me 
2-CI Orange-
H Colorless 
2-OH Rust 
2-0CH, Purple 
Orange 
2-CF, Orange 
2-CF, Salmon 
2-S-CH, Purple 
0·206 x 10' 
0·0 
0'754x 10' 
0-419 x 10' 
0-404 x 10' 
0-247 x 10' 
0·226 x 10' 
1-005 x 10' 
SKF 5915 (CH) NMe 3-C1 SI Purple 1-142 x 10' 
t In the case of chlorprothixene, C r:p;ace:::~s-;~:'-. ----------------------------'------------
'In the case of imipramine, a CH.-CH. group replaces S. 
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Figure 12 Absorpt1on spectra 1n ultrav10let range for so •• 
. 
phenothiazines.t A. Th1opropa:&ate, B. Perphenaz1ne. Absoissa: 
vavelength (~) in ~ Ordinate: optioal density (O.D.). seckman 
DU speotrophotometer was employed. Drug ooncentrations, 20 
miarogm. per ml. 
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Figure 8: Absorption speotra in visible range tor SODl8 phenotbia 
zinesl A. 2-MethoxypromazineJ B. 2-HydroxypromazineJ C. Thiorida 
sin.; D. Fluphenazine, E. Imipramine. Abaoiasat wavelengtb (i\) 
in~. Ordinate, optical density (O.D.). Beokman B speotropho-
tometer was employed. Drug conoentrations. 20 microgm. par ml. 
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Figure 91 Absorption speo_ra 1n visible range tor some pheno-
thiazines: A. Ohlorpromaz1ne-N-oxide; B. Thiopropazate; O. SKF 
4514A. Absoissas wavelength (I\.) in mp.. Ord1nate: optioal 
dens1ty (O.D.). Beokaan B Speotrophotometer was employed. Drug 
concentrations, 20 miorogm. per ml. 
wave range (3$0-650 ~). CPZ-NO, thiopropazata, SKF 4S14-A 
(Norl Cpz) and perphenazlne (Pigs. 7,8) whioh difter trom OFZ 
only in substitutions on the X-alkyl ohain (Table 2) .xhibited 
speotra similar to that of CPZ (Fig. 2); their colore4 reaction 
products were Identloal, by vlsual observations, wltb the cherry-
red ohromophore ot CPZ. Pigures 9A abd 9B show absorptIon spec-
tra for two phenothiazines, whioh while having tbe lO-dimethyl-
aainopropyl group as the side ohain on the riag nitrogen, d1tter-
H trom OPZ 1n that the ohlorine atom in the 2 position 1s replac-
ed by either a setboxy or hydroxy group. It is apparent that the 
respeatlv.absorption spe.tra d1ffered in the visible range. 
Other substltutions for the chlorine atom in the 2 positlon also 
resulted in differently oolored reaotlon produots. For example, 
thiorldazine (Flg. 90) yielded a purple 00101', while promazlne, 
fluphenazine (Fig. 9D), and tritlupromazine produoed varlous 
sbades of orange (Table 2). Also, substitutions of ohlorine .1 .... 
where in the ph.nothiazlne nucleus led to reaotion p~oducts dit-
tering in color troll OPZ ('able 2). Flnall,., Itl terations i~ the 
moleoular struoture of the lIIhenothiazine nucleus, suoh as "PeDloval 
ot either nitrogen or sulfur atOll, altered the chromophore •. 
Cblorprothlxene produoed orange 00101". Imipramine (Fig. 9E) re-
mained colorless in the prooedure {Table 2}, and its presenoe did 
not intertere in the determination of CPZ. 
Sinoe it appeared that the method was specifio tor 2-
chlorophenothlazine. with a N10-aide chain (2-CPN), this method 
could be expeoted, in vivo, to assay OPZ and soae metabolites 
struoturally related to it. Aooordingl,., pertinent data pertain-
ing to the tissue distribution are expressed in terms of 2-CPN, 
rather than CPZ, eveD when under oertain oonditions, only the CPZ 
oould be expeoted to be pI'.sent. 
The l'eaults indioate also that the extrllotion and 
analysis method deseri.ed here oan lend itself, atter luitable 
studies, to di:t'fettent1al ana.lysil of 011nioa11'1 important pheno-
thiazine. other than CPZ. 
'1'i.aue Distribut1o! :2! Ch lorprolll9.zine 
Thirty seoonds after rapid intravenous injection of 
OPZ, 40 microsm. per gm., 2-CPN concentrations in whole blood 
varied betwe.}n ,300 and 500 miorogm. per Illl (Fig. 10). ninety 
aeoonds later, oon~entratlons were reduoed to 120-140 miorog •• 
per m1 (Fig. 10). Respiratory and oardiao arrest oeourred about 
thia time. In the oase of oatl given CPZ b,. slow injeotion, the 
levels of 2-0PN In the blood deoreased to 10.20 miorogm. per ml 
within seven minutes atter ita administration (1'lg. 11). '!'hil 
level of 2-CPN in the blood remained essentially unohanged during 
the subsequent tort,..elght hours (Pig. 11). 
The earl1elt ana17sis of brain (oerebrum). heart, liver, 
and lung was oarried out fitty aeoonds atter rapid administration 
of CPZ. High oonoentrations (0.8 and 1.1 mg, respeotively) of 
2-0PB were tound 1n the heart and in the lung, where 2-0P5 waa 
eater 1iha 
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Pigure 101 Blood leyels ot OPZ atter rapid intravenous injection 
of 40 mioros •• per gm. Abso!ssa: tim. in seoonds; ordinate, 
whole blood level in mlorogm. CPZ per m1 of blood.. Data obtained 
in two oats, eaoh point represents duplicate readings. Fir.' 
two readings obtained 1n a third animal, whieh di.d 50 aec. atter 
medicatien were in 11a. with those illustrated i thia £i 
44 
E 200 E200 • • 0> 
-!(' ~. 
---\ '- E ( • Lim <f) E 0> 0 100 0 ~ ~ 100 0> 
-.--0 
.......... 
~ ..... ~ u Blood 
........ 
• ~ 0 ,eGe " e e 88 ......e---8--o 
\ 't---\ 't---\ T--\ \-- 0 \ 't--\ 't---\ \--\ 't-2 3 8 12 24 48 2 3 8 12 24 48 
·//22 
500 
800 
• E 
-!(' 
E 400 • <f) 
§600 0> 
'- ~ 
<f) 0> 
E 0 
... 
~ 300 u ~400 • 0> 0 
... 
u 
• ~ 
200 ----......, 
• ...... 200 Heart 
• 100 • 
-----\~~T--\\-- 0 \ T--\ \--\T--\~ 2 3 8 12 24 48 2 3 8 12 2448 
HOURS HOURS 
" .-+----~ 
Figure 11. tevels of 2-CPN in five seleoted tissues after slow 
intravenous administration of 40 p..g/gm. In all four plots, ab-
scissa represent bours (notice five ohanges in time soale) and 
ordlnate--~g/gm of tissue (notioe that the oonoentration soala 
ohanges from plot to plot). Each point represents average. ob-
tained f~o. duplicate readin a in at least tw 
4$ 
time (Table 3). Liver and oerebrum exhibited levels of 2-CPN of 
64 and 168 miorogm. per sm. respeotively (Table 3); these leve1$ 
were lower than those found at fitty seconds in the blood. At 
tour and six minutes, 2-0PN levels in the oerebrum (Table 3) and 
other parts of the brain (Table 3) were muoh higher than in blood 
thus, 2-CPK oontent of the blood, present in the tissue. investi-
gated, oould not appreoiably oontribute to the total 2-0PN tound 
In the tissues. The level of 2-OPN 1n the cerebrum exhlbited a 
transitory deorease from 168 m1orog~: per gm. at fifty seoonds to 
111 mlorogm. per gm. at four to five minutes (Table 3, Fig. 11). 
Maximum conoentration of 2-CPB tor the oerebrum appeared at about 
forty.flve minutes. Thereafter, 2-0PN content of the oerebrum 
d.olined slowly. At twenty-four and forty-eight hours, oonoen-
trations ot 2-0PN in brain were about 70 miorogm. per gm. and 
30 mlorogm. per gm. respeotively. 
Besides oerebrum, aeveral other brain areas were ana-
lysed tor 2-CPN at various time Intervals following OPZ adminis-
tration (Table 4). The oerebrum. hippooampus and various braIn 
atem areaa had oonsistently higher OPZ ooncentrations than the 
oerebellum, the difterenoes, while statistioally signifioant, 
never exoeadeQ $0 per oent, and generally, were much le.s (Table 
4); the ditterence. between oerebruM, brain stem and hippooampus 
were even less marked.* Also, the general pattern ot the slow 
decrease ot 2-0PN level, following its 30-60 minute peak, was 
* a.. appendix 
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Chlorpromazine distribution in the cat 
TABLE 3 TISSUE LEVELS OF 2-CPN AT VARIOUS TIMES AFTER ADMINISTRATION OF 40 f'G/GM Of CPZ 
Average values in pg/gm. Numbers of cats per determination in paremhesis. Determinations carried out 
in duplicate. 
Min Hr 
Tissue 0·83 4-6 15 30 45 60 132 160 8 12 18 24 48 
Cerebrum 168 111 157 164 182 151 140 116 83 81 67 32 
0) (2) 0) ~3) ~I) ~2) ~2) 0) (2) (2) (2) ~2) 
Heart 779 459 426 129 96 69 58 80 36 3"9 44 25 18 
0) m (2) (3) (I) (2) (2) (l) (2) ~2) (I) (2) (2) 
Lung 1122 420 448 258 128 160 101 1~ ~ 242* 181 210 182 
(1) (2) (2) (3) (1) (2) (2) (1) (1) (2) m (2) 
Liver 64 34 120 170 194 162 185 205 190 210 113 68 
(I) (2) (I) (2) (I) (2) (2) 0) (2) ~2) (2) (2) 
Kidney 83 1<19 86 102 83 25 
(I) (2) 0) (2) 0) (2) 
Fat 18 48 22 11 96 145 30 94 54 48 25 
II) 0) (I) ~I ) ·(3) (2) (2) (I) (1) (2) (2) 
Spleen 53 128 87 34 
(I) (1) (1) (2) 
Pancreas 131 
(I) 
Testes 80 66 
(1 ) (1) 
Sciatic 
Nerve 48 59 
(2) (I) 
Diaphragm 
Muscle' 116 66 
(1) (I) 
*An additional cat showed an unexpectedly low (40 pg/gm) lung content of 2-CPN. Values for its other 
tissues were as expected and are included in this table. 
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TABLE 4. BRAIN LEVELS OF 2-CPN AT VARIOUS TIMES AFTER ADMINISTRATION OF 40 p.G/GM OF CPZ (in p.G/GM) 
All values represent duplicate determinations in single cats. Values for the cerebrum contribute to averages 
in Table3, except for the 85 min value. 
Min Hr 
Tissue 4 6 30 60 85 132 160 24 48 
Cerebrum 112 110 171 154 130 171 184 146 116 63 29 
Cerebellum 67 71 120 119 96 102 45 27 
Brain Stem 85 77 131 103 47 
Mesencephalon 166 148 
Pons 126 
118 
Medulla 108 
Hippocampus and 
Thalamus 116 132 40 
48 
s1milar for the four brain areas 1nvestigated. 
A high level of 2-CPN persisted in the heart for tif-
teen minutes after OPZ 1njeot1on (Table ). This level dropped 
abruptly atter thirty minutes (from.more than 400 to about 130 
microgm. per gm.) and more slowly thereafter (Fig. 11). After 
forty-eight hours, 2-CPN content of the heart was 18 m1\lrogm. 
per gm. (Table ), Fig. 11). 
Lung, like heart. exhibited very high levels of 2-CPN 
1mmediately after its administration (l~l mg/gm). The level was 
still very high ten m1nutes later; 1t decreased abruptly to the 
level of about 100 mio1'Ogm. per "JUl. within the next two hours. 
However, unlike in the heart, this deoline was reversed; the 
level of about 200 miorogm. per gm., reached at about 160 minute. 
remained easent1ally unohanged for the subsequent forty-eight 
hours (Fig. 11, Table 3). 
Oomparatively little Z-CPN appeared in the liver during 
the first six minutes after OPZ intravenous administration (Table 
3). Subsequently, the liver Qontent of 2-OPN increased to a peak 
which was some six times higher than the six minute value (Table 
), Pig. 11). After one hour, the level of 2-CPN in the liver 
was as high as that in the cerebrum or lung. It remained rela-
tively constant during the subsequent twelve hours; as 2-CPN 
levels in oerebrum declined during that time interval, the liver 
became, at twelve bours, the organ with the highest 2-CPN content. 
Thereafter, the amount of 2-CPN in liver decreased rapidly; the 
forty-eIght hour value was approximately 70 miorogm. per gm. 
('ig. 11, Table 3). 
During the tirst forty-rive minutes after CPZ adminis-
tration, rat levels of 2-CPN were relatively lo~ (Table 3). 
Higher levels were reoorded thereatter, a peak value of 145 
mioroga. per gm. was reaohed atter two hours. Then the fat oon-
tent of 2-CPN deoline4; the values of 46 and 2$ microgm. per ga. 
were reoorded at twenty-tour and forty-eight hours, respeotively 
(T.'lble 3). 
Further analysis demonstrated that 2-CPN was distri-
buted to pr.otioally ~very tissue (Table 3). 'l'he spleen oontaine. 
128 m1orogm. per gm. atter two hour., and the kidney oontaine4 
almost 200 microgm. per gm. aft~r thirty minutes (Tabla 3). 
After forty-eight hours both these tissue. showed levels at CPZ 
at about )0 miorogm. per gm. 
. The relative level of 2-0PN in tissue may depend on 
the dose of OPZ; this possibility de.erved speoial attention in 
view of the faot that the dose of 40 miorogm. per gm. would oor-
re.pond to the total dose of about 2.8 gm. in the buman, whiob I. 
high tor a single dose in a human. Levels oT 2.CPN were measured 
in two oat., one hour after the intra.venous administration ot 20 
miorogm. per gm. of OPZ. The average 2-CPN oonoentration in 
various tissues was (in miorogm. per gm.): lung, 124; liver, 97; 
kidney, 75; heart, 49; blood, 10; inguinal tat, 14; oerebrum. 94; 
oerebellum, 91; midbrain and pons, 76; medulla, 6). The •• levels 
SO 
were generally somewhat higher than those that oOllld be expeoted 
on the basis ot besults obtained with the larger dose. The gen-
eral trend was similar with both dosesJ 2-CPN aooumulated in the 
lung. liver, kidney and the brain atter the smaller dose as it 
did after the larger dose. Cerebrum exhibited the highest 2-CPN 
level among the parts of the brain investigated, as in the oase 
ot 40 miorogm. per gm. dose of CPZ the ditterence. were not 
marked. 
Pharmaoolosio Findings 
~ne gross pharmaoologio effects were observed in 
thirteen cats. Shortly after the start of the injeotion of OPZ, 
40 miorogm.per gm., the animals beoame relaxed, the respiration 
depressed, and the pupils dilated. Applioation at the htullostat 
clamp onto the tailor the toe pad produced no response. Thus, 
the animals resembled those in plane 2 or ), stage III, of ether 
anesthesia. Twelve hours atter OPZ administration, painful stim-
uli caused no ilnmed1ate response. Upon repeated stimula t:1(\n a 
dela1ed response oocurred} the Qst withdrew the paw or the tail, 
and emitted a weak cry. Even thirty hours after OPZ administra-
tlon, the oat still responded to paIn stimulI with a oharaoteri ..... 
tio 3-5 8800nd delay. Forty-eight hours after CPZ administration 
the response was immediate, but the slight cry and attempt to 
move the afflioted 11mb were not aooompanied by aggression. 
Co-ordinated motor aotivity was absent ten to eleven 
hours following the injection of CPZ. The righting reflex was 
poor or absent for approximately twenty-four hours. However, at 
twelve hours, two of the thirteen oats made attempts to lap milk 
or to ~alk. Interest in these aots waned rapidly. Food placed 
into the cage usually was not eaten fo~ty hours after the Injed-
tion ot OPZ.gven forty.eight hours after receiving medioation, 
the animals exhibited no sustained motor activity, and mainly 
rested or slept, agression and resistance to ~ough manipulations 
or handling were absent. Relaxation of the niotitating membrane 
was appa.rent for more than torty-eigbt hours. 
In the study ot the hypothermio aotion ot 6PZ, tour 
unmedioated oats, restrained for seven to twenty-tour hours, re-
vealed lIluimal reduotion in rectal temperature of .4.2 t 0.9 F. 
(Fig. 12), whioh ooourred af~er immobll1zation ot about four 
hours. Immediately upon their rele&~e, the temperature roae. 
Levela recorded prior to the restraint were a.ttained in .about an 
hour. CPZ. 40 miorogm. per gm. intravenously, was administered 
to these animals restrained 1n a harness. The cats were released 
from the harness two hours (1 animal), eight hours (2 animals), 
and forty-eight hours (1 animal) atter medication (Fig. 12). 
Maximal hypothermia was 8.6 t 1:06 H; it oocurred independently 
ot the t1.e ot the te-"mination or the restraint, eight to twelve 
-. hours after medication. Altogether, c~~ hypothermia was abuut 
double that produced of restraint; sinoe at the end of hypothermic 
erteots (24-32 hours atter medioation) the oats, while motile, 
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Figure 12. The eftect or intravenously administered ohlor~oaa­
zine, 40 mg/kg, on the reotal temperature of the oat. The ourves 
rerer to the control period ~ and to the ohlorpromazine ettect 
period • tor that oat. The arrow indioate. the time that the oat 
was released from the restraining apparatus. Abscissa: time in 
hours. Ordinate. temperature in degr ••• Pahrenheit (OP). 
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were still sedated, it is diffioult to aay whether or not hypo-
therala was seoondary to sedation. 
Equilibrium Dialysis Stud: ~ Tissue Bindi~ ~ ~ 
POl" purposes of clarification pertaining to the obser-
vations obtained by equilibrium dialysis it is neoessary to de-
fine the terms "unbound", "bound", and "uptake". Unbound drug 
reters to the drug whioh has not entered into a oomplex with 
either the tissue homogenate proteins, enzyme., or oellular oom-
ponents, or the oellulose casing employed in these experiments. 
Unbound drug oonoentrat10ns are those found from analysis ot the 
outer compartment. The usage of the term "unbound" drug a8 op-
posed to "bound" drug shall be employed in this text. The term 
"bound" drug shall reter to the difference in oonoentration 
(Dd.orogm. per ml) of the drug in the inner and outer compart-
ments, providing of oourse, that the inner cha.mber exhibits a. 
higher oonoentratlol'1 than the outer ohamber. This applies only 
if equilibrium has been attained. The per oent bound drug will 
refer to the ra.tio ot the amount of bound drug to the amount of 
drug found in the il'1ner oompartment at the end of the experiment. 
The term "uptake" employed in the text refers to the amount of 
CPZ, bound and unbound. ~vhioh had been found inside the dialysis 
bag at the termination of that partioular experiment. 
Effeota·ot !himeroaal 
Aliquot8 plated tro. the preliminary equilibrium 
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dialysis experiments revealed a number of baoterial oultures 
whioh grew in the outer ohamber ot the reaotion vessels. Identi-
tioation of these baoteria was not attempted. Sinoe baoterial 
growth oan introduoe unknown faotors and mar result in the metab-
olism or oxidation ot the OPZ moleoule, it was deemed advisable 
to seleot some suitable substanoe or technique to eliminate pos-
sible baoterial interrerenoe. Perrormanoe or experiments at low 
temperatures reduces the rate of baoterial growth. However, the 
tnaooessibility or cold-roo. faoilities required the utilization 
ot other teohniques. The introduotion of thimerosal at the tinal 
oonoentration ot 0.16 mg ~ (O.OOOl6~) eliminated baoterial growth 
in these experiments. Table S shows that tull reoovery of' CPZ 
was etrected in the presence of thimerosal. Tests tor baoterial 
growth atter the introduotion of thimerosal solution in the re-
aotion vessel were negative. Theretore, baoterial plating waa 
not performed routinely. 
ThuI, thimerosal did not change reoovery as shown in 
table 1. The lower OPZ recovery from the experiments laoking 
thimerosal (Table 5) may possibly be suggestive that OPZ may be 
metabolized in tne presenoe of baoterial strains. This interenoe 
must be interpreted with caution ainee no attempt was made to 
pursue this observation; furthermore, ph.enothiazines have been 
known to reduoe baoterial growth (68). Reooveries observed in 
the presenoe of baoterial growth (Table 5) were not signifioantly 
ditterent trom the lower limits of the reoovery reoorded in 
5S 
table 1. 
Table S 
!he Effect of Thimerosal on the Recovery at Chlorpromazine 
during Equilibrium Dialysis 
Brain homogenates (1:) were dialyzed for 20 hours at room 
temperature, pH 6.8. Volume of solution in outer chamber, 
30.5 mll inner ohamber volume 4.5 ml. Initial CPZ oontent, 
8790 microgm. 
t 
Thinaelto.al L CPZ Reoovered ~g) !C Recovered 
I Inner I Outer Total I Chamber I Obamcar 
(ml) (A) I (B) (A+:!) 
'lONE 3546 I 3)60 6906 78.6 
I 0.5 5148 )812 8960 101.9 I 
; 
Binding ~ Diallsi8 Bas 
Consideration was given whether CPZ would bind signifi-
oantly to the d1alys1s bag. To asoertain the error whioh may be 
introduoed by the binding at CPZ to the oellophane bag, deter-
minationa of CPZ tram both, the inner and outer, ahasbers were 
performed, total CPZ estimated and the reoovery oaloulated. 
Table 6 shows that the reooverie. obtained by analysis at both 
inner and outer solutions from a series ot experiments averaged 
98.$7 per oent. This indioated that the binding of CPZ to the 
oellulose caslngs was negligible or reversible. 
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'fable 6 
Reoovery ot CPZ Following Equillbrium Dialysis 
Brain homogenate. 1:10 were dlalyzed for varylng time perlod. 
at room temperature; pH 7.12. Volumes of solution in outer 
ohambers equal )0.5 ml., Inner ohambers volumes, 8.0 ml. 
Inltial CPZ oontent 10560 microgm. in each tube. Mixing 
produoed by magnetl0 stirrer. 
Dlalys1s CPZ Reoovered (mlorosa) Ditferenoe ~ Duration Ou;er Inner To"a]. trom in1tial Dltterence (Hours) Chamber Chamber oonoenlrratlon 
(A) (B) (A+B) 
1 6889 1381 10,270 
-290 
-2.74 
2 8697 2130 10,827 267 2.53 
4 6780 3624 10,404 -156 
-1.48 
6 6039 4512 10,551 
-
9 
- .08 
8 3715 I 6372 ! 10,087 -473 -4.48 
16 3556 6657 1 10,213 -241 -2.31 
~ 
, 
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Ette.t !! Varying Q!! conoentratlon~ 
High Initial oonoentrations of the drug could establish 
an equI1Ibriua whioh would saturate the inner hOMogenate solution 
to the extent that the existence of binding would not be re-
flected. The etrect ot inoreases of the CPZ oonoentration oJ the 
bInding by oerebrum homogenate. (1:100 dilution) resulted in a 
lineer., inorease in uptake at four hours (Fig. IJA) and at six 
hours (Fig. l)B) tor CPZ oonoentr.f!tiona investigated. No experi-
ments were oarried out in which the initial CPZ oonoentration w •• 
increased to the level at whioh further inorements resulted in 
no greater uptake of CPZ by that partioular homogenate conoentra-
tion. Sinoe a oonoentration ot 1 mM did not appear ~o be near 
the limiting conoentrat10n tor CPZ uptake. this oonoentrat1on 
was employed 1n subsequentJ.x.pe:"i~ents~ 
Ette., !£ Difterent M1xins Teohnique. 
Equilibrium in the oontrol experiments was atta1ned at 
approximately six hours when the magnetic st1rring bar (Fig. l4A) 
or the Eberbach shaker (Fig. 148) oonstituted the method for 
m1xing. Comparison of the two shaking methods ror the binding ot 
OPZ, employing 1:100 brain homogenate., revealed that a alight 
ditterenoe ocourred in the time to atta1n equilibrium (Fig •• l4A, 
B) •. By means ot the magnetio stirring meohanism the uptake pro-
o.eded somewhat slower than that obtained by the Eberbaoh shaker. 
Al.oateight hours were required to atva1n equ1librium by the 
58 
Brain Homogenates 1:100 
300 
-
A 
t: 
Q) 
E 200 4 hours 
-~ 
0 
c.. 
E 
0 100· 
Ii U 
~ 
Q) 
t: 
t: 
-
E 300 
~ B Q) 
c.. 
N 6 hou rs 
Cl.. 200 
() 
0' 
E 100 ., 
Q) 
~ 
0 
-c.. 
:::> 
o 0.2 0.4 0.6 0.8 
Initial CPZ concentration (mM.) 
.-' 
Figure 13: Effeot ot<"arious OPZ conoentrationa on uptake b'1 
oerebrum homogenate. (1.:100). A. Uptake at 4 bra. (pre.equ111b-
• 
r1um). B. Uptake at 6 hrs. (equilibrium). ~. ourve. repre.ent 
oontrols a and homogenate 0 • Room •• mperatur •• pH 7.12. 
Abaolaaa: In1t1al OPZ t,oncentra.t~on 1n MM. ordinate: uptake, 
er ml 1n 
S9 
800 A x Cerebrum (I: 10 homogenates) 
600 
400 
c: Cerebrum (/' 100 homogenates) 
Q) 
E 200 
- Control ~ 0 
a. 
E 
0 0 u 
~ 
-800 Q) 
c: Cerebrum (I: 10 homogenates) c: 
--
-E 600 
~ 
Q) 
a. 
N 
(L 400 
<.) Cerebrum (I :100 homogenates) 
E 
0 
~ 200 CJI Control 0 
~ 
u 
E 
Q) 0 
..x: 
0 400 C • -a. Cerebrum (1:100 homogenates) 
=> 
200 
0 
4 8 12 
Duration in hours 
Figure 141 uptake of CPZ by oerebrum homogenatesl A. Room tem-
perature, rrdxing by magnetio stirring bar; B. Room temperatnl*e, 
mixing by Eberba,b shaker} C. At 0-4 0 C. m.ixing by Eberbaoh shak-
81'. The ourve. repre.ent oontrol a •• ~mblie. 0, homogenate. 1:100 
•• and hOllogenat •• 1: 10 x, at pH 7.12. .Absoissa: Durat10n in 
hour., Ordinate: U 
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former technique whereas equilibriuM was attained within six 
hours using the latter shakIng mechanism. From exaalnatioD ot 
figures l4A and 148, it may appear that the magnetio stirring 
technique resulted in I:l greater uptake of CPZJ however. tt-is 
ditterenae was within the range of variability ot tha analytioal 
method employed. 
Ette,at .2! Temp.ra~ .2!! m Uptake 
The seleotion ot lower te~peratures to pertorm equilib-
rium dialysis by i.Uos't investigators stems trom the knowledge that 
lower temperatures tend to limit or reduce protein hydrolysis and 
. denaturation or enzyme destruotion. The uptake of CPZ by tissue 
(oerebrum) homogenates was measured in the presenoe ot thimerosal 
at 0-4 "c and at 24-26 0 0 (room temperature) .. 
ApPl'Opriate controls Were performed in both experiments 
The oontrols at the two temperatures attained equilIbrium at 
approximately the same time. Equllibrium for cerebrum homogen-
ates (11100) oocurred at about eight honrs at 0-4 C C (Flg. 140), 
and wit!tln six hoUl's at 24-26°0 (Fig. 148). Little differen •• 
in the uptake of OPZ at equilibrium was evident at th~se two 
temperatures (Figs. 14B and l1.e). althQugh the period to attain 
equilibrium was longer at the lower temperature. Somewhat simi-
lar effeats of temperature upon the binding of other organI0 
oompounds had been reported by KIGtz et ale {58} and Da"lison and 
Smi t11 (60).. Evaluation of the kinetios ot temperature etfeat waa 
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Efteot 2!. Tissue Homogenate Concentration 
An increase In the tissue homogenate oonoentration 1n 
the inner chamber resulted in a greater uptake of CPZ (Table 7). 
A ten-fold inorease of homogenate concentration resulted. in an 
uptake that was almost doubled. Thus, oerebrum homogenate., 
1:10. exhibited a mean uptake of 773 ! 53.5 miorogm. CPZ per ml 
as oompared to 407.3 ± 21.6 miorogm. CPZ per m1 tor oerebrull 
bomogenates 1:100. T~e per cent b~nd CPZ also increased at 
higher oonoentrations of tissue within the homogenate. Thus, 
1:10 oerebrum homogenate dilutions exhibited approximately 87.2 t 
2.95 per oent bound CPZ as compal'ed with 55.1 t 2.02 per cent tor 
; 
1:100 oerebrum homogenates (Table 7). 
Eftect ot Aged and Boiled Cerebrum Homogenates 
---
Cerebrum homogen~~es ot two oats whioh had been sub. 
jeoted to heat.ing at 90 0 C revealed no apparent (Utterenoe in the 
uptake ot CPZ compared to unheated homogenates (Table 8). Also, 
oerebrum homogenates aged from two to four weeks exh1bited uptake 
o~ CPZ essentially similar to that ot the tresh11 prepared homog-
enates (Table 8). 
Efteot ExhibIted Ez Various Tissue ~_omogenates 
Uptake ot CPZ ooourred tor all the tissues studied, 
inoluding blood. It was found with the pre~ent experim~ntal 
oonditions that 1:100 homogenates ot liver, brain, heart, and 
lung were capable ot interaot1ng with CPZ to approx1mat~11 the 
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Table 7 
!he Eftect 01' Varying Concentrations ot Tissue Homogenate 
Preparation Upon the Uptake of CPZ 
outer solution volumes 30.5 mil inner solution volume 10.0 
ml; pH 7.l2. Cerebrums rrom two oat. were used. Each 
dialysis duration ex ••• d. tbe equl11briua period. 
--
Homogenate I Dialysis j CPZ oonoentrations , ! ~ : Oonoentration Duration miorogm. per ml* Bound I 
I 
-,------. r-"-----r---"---- CPZ I ! Dilution gm. wet wgt. I outer Inner, 
I tt •• ue/ml I Chambep Chamber 
I ! _ (Uptake) i 
I I-
i 1,10 0.1 6 109 716 84.8 I 
! 1:10 0.1 8 122 792 84.7 
i 1:10 0.1 8 7) 717 89.8 , 
i 1:10 I 0.1 8 73 j 808 91 ! I 1:10 0.1 16 i 117 832 85.9 i r------ --
I MEAN + S.D. 1'13 ! 53.5 87.2! ~.95 
-- - _.-,--" ~,~,~--
---'----" I I 1:100 0.01 6 192 402.5 52.4 1:100 0.01 8 191+ 
" 
410 52.5 
1:100 0.01 16 172 ': )90 56 ! t 
1:100 j i 0.01 18 
; 175 399 56.1 . i~ 
i 1:100 0.01 24 175 " 401 5b.4 ~ i 1:100 , 0.01 24 I 192 , 454 57.7 ! i I 1:100 1 0.01 I 24 rl9 I 394.5 54.7 I ! , j r---- i I 
" ~ }ligAN! S.D. 407: 21.6 155.1 ± 2.02 , i 
~~Each figure is the average of duplicate CPZ analysi. 
, 
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'1'ab1. 8 
uptake ot OPZ by Oerebrua Homogenate. Subje.ted to Various 
Treatment 
Brain homogenate. 1:100 were used. outer solution volume., 
,30.5 ml; inner solution volumes, 10.0 m1; pH 7.12. Initial 
OPZ oonuentration averaged 346 miorogm. per ml. 
Souroe of Experiment 
Homogenate Duration 
(Houl's) 
Conditions I uptake of CPZ 
ot ( moroga/vJl *' 
Experiaent I 
Temp ... Stirring · 
---.---------+----------+-----~--------~------------~ 
Oat #1 
Fresh Room Hagnetio, 
Room Magnetic 
3.50! 3 
324 t 21 
I 
Aged 
Ballad 
6 
6 
6 Room Mllgnet10 i 
.386 I 
-.~-- .. -.+-----.-.. ~ ..... - ~-.-... ~-.. -.. ,.- ,-..... ,-.-""'-~,,".'" .... ,--,-.---.-, 
Cat fl1 
FJ:ge.h Room Magnet!o 454! 1 I 
Boiled 
Oat I/Z 
Preab 2. 
2 
I
' Roo,m_ --1-1 M_tlg_D_ •. __ t_l,_o....:-_. __ 47_0_:_1 __ 1 
Room ,I Eberbach 264 t 5 
Boil.d I Room 'Eberbaoh: 238! 4 
r-a-R-t-#~2----+-------·~I-----+-------r----------
Fresbr 4 Room Ebarbaon I 
: 
Boiled 4 Room· Eberbaoh t 
I 
Cat 12 t 
Fresh 6 Room Eberbacn f 
r 
Boiled 6 Room Eberbaoh I 
358 ± 2. 
311 
401! 9 
402 
cat 112 
Frosh 
,--
24 0-4°0 Eberbaoh I 417 i 2 
1 __ Bo_il_e_4 ____ 24 __ ---:..I_O_-4_o_o __ JJ_be_l"_b_a_O_h_' __ 4_2_2---
*Pigures inolude average t range (a minimum ot .2 
analyses for each figure). 
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s .. e extent (Figs. 140, 15A, B_ C). With all tiISU •• , the maxi-
DlUm uptake at room temperature ooourred at about six to eight 
hours. 
'Whole blood, diluted 1:10, whioh contained heparin as 
the antiooagulant, exhibited an uptake of CPZ whioh diftered 
trom that obs<::rvod with the other tissues. Table 9 compares the 
uptake and the ~er cent bound CPZ dt the blood obtained from one 
oat to that or cerebru. lslO and oerebrum 1:100 homogenates prer 
pared tram another oat. When whole blood, diluted 1:10, oonstl~ 
tuted the inner medium, blood extrl.blted an uptake le88 than that 
found tor a similar 1:10 dilution tor brain homogenate. A muoh 
lower uptake was antioipated, beoause of the results in vivo, 
indioating that l1ttle CPZ was reta.insd in blood. The uptake and 
per cent bound OPZ observed in blood, diluted 1:10, in vitro, ma7 
be oomparable to the lower dilution (1:100) ot the tissue homog-
enat •• (Table 9). 
One experiment "'.las pert'ol"lIed whereby ttndiluted. h\tparin-
1.8d blood, to which Cl'Z was added, constl tutttd the so1u·tlon of 
the outer chamber. Tbe design of the ,,;Xi)SItiment was similar to 
that desoribed for competition between the tiss~es for CPZ, that 
Is, four tlssuft homogena.tes oonsti 'tut~d the inner ohambers. 'rhus 
10.0 1Ul homogenates (1:100) of ear.brunt, heart, livel-, an4 lUng 
vere suspended in separate d1alys1s ba.3S in 96 '1ll ot the heparin-
ized blood. Fo1" eaoh tissue, tht) uptake par m1 ot homogenate 
(Table lQ) vas. in this expertmentl, approximatel., 10 per oer.rt ot 
6S 
400 0 
0 
300 
200 
-c LUNG: (1:100 homogenates) .. 100 E 
-
.. 
0 Q. 0 E 
0 0 ~400 0 
.. 
c 
C 
....: 300 
E 
.. LIVER: (1:100 homogenates) 
8-
N 
Q. 
0 
~ 1 
.. 
00 
0 
.. 
u 
'E 0 
.I 400 
0 
-
Q. 
=>300 
, 
200 Heart (1:100 homogenates) 
100 
I i 
0 2 4 6 8 10 12 14 16 18 20 
Duration (hours) 
Pigura 15: Uptake of CPZ by tissue bomogenates 1:10-); A. tung; 
B. Liver; G. Heart. Mixing etteoted by Eberbach variable speed 
sbaker. Roo. temperatura, pH 7.12. Absoissas Duration in 
hours, O~dinat.: Uptake; miarogm. CPZ per ml inner oompartment. 
'fable 9 
Uptake of CPZ by blood, in oompa.risOJl to aerebrwa. homogeDat. 
Outer a~lution volumes, lO.5 mll inner solution ~olumea. 
10 ml. pH 7.12. Initial CPZ conoentration 3$0 miopogm. 
per ml~ Mixing b7 magnetic st1rring ba.. 
Tisaue Exper1llen t Uptake ot CPZ % Durat10n (udcrogm/ml)* Bound. (Houra) 
Control (ECj,1.li11br1u.) 6· 232 t 13 
. 
Whole blood lrl0 6 334 t 18 
Cerebrum 1,10 6 S64 ! 18 
O.Hbrum 1:100 6 3S0 ± J 
WAole blood 1110 18 ~l07 ! , 
aare'brWl 1:10 16 8)2 
Ca •• bru. 1alOO 18 )99 t 10 
*FIgura. inolude averaga t l'anse (2 ana.l,..e. per each 
figure) • 
CPZ 
47.4 
64.) 
40.4 
60.3 
85.9 
S6.1 
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the Ini~lal CPZ oonoentration ot the blood--a level tar less than 
that expeoted trom the comparison of the results obtained in vivo 
where very little CPZ was fOlmd in the blood because the tissue. 
exhibited signifioant uptake (.ee results p. 44). Thus, OPZ was 
not bound by the tissues when undiluted whole blood constituted 
the outer •• diu. of the equilibrium dialysis chamber. 
!able 10 
Uptake ot CPZ by Various Tissue Homogenate. in the Presenoe ot 
Blood 
outer solution oontaining )68 ! 7 microgm. CPZ per ml oonsisted 
ot 96.0 .1 hepar1ni.ed Whole blood plus 2.0 a1 thi.erosal. The 
d1alysis bags contained 10.0 ml ot the respeotive tissue homog-
enates (1:100) in phosphate bufter, pH 7.12. Duration ot exper-
iment 6 hours at roo. temperature. Mixing etfeoted by magnetic 
stirring bar. 
Tissue 
HOllOsenate 
Cerebru18 
LiYel' 
Lung 
312 
)2.0 
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Sinoe 1 ·mM oonoent~atlon8 ot CPZ preoipitated in 
phosphate butter at pH 7.4, CPZ ma1 have preoipltated 11'1 the 
blood (pH 7.4), an etteatwhich would aftect the results. How-
eYer, under the experl.ental oonditions, the pH ot the blood at 
the termination ot the experiment was 7.2. 
Ufeot .2! ooewetltlon 2! Tissue. 
'.1"0 detern:tne \ihether oOlllp3tl tion between the various 
tissues oocurred in vitro J dialysis ba.gs oonta.lning the .. tissue 
homogenate were suspended in a beaker ot buffered CPZ solution 
10 that the ratio 1;.3 total homogenates to buttered ~PZ prevailed 
e.s l~ the uptake experiment~ (sea Mothods, p • .3.3). At the d .... 
ignated intervals aliquots uere Analyzed as desoribed under pro-
aeduNs. 'tho results of these experiments are shown ltl Table 11. 
Uptake of CPZ by each of thasQ tissues appeared tp b. sl~lar. 
Further experimentation is neoessar,. to determine whether the 
slightly larger uptake ot CPZ exhibIted b1 liver homogenate. 1. 
atatistioally signifioant. Thul, in theae experi •• nta, the dif-
teren.e. in tissue uptake observed in vivo did not ooour. 
Attialt: !! cerebrum aomogenates ~ ~ 
To teat tor affinity of the tissue for CPZ, duplioate 
equil1brlua dlalysis assemblies were prepared. One assembly 
served as • oontrol. The bags were removed at the same t1me; 
one of the bags was blotted dry on tissue paper arid resuspended 
in a oba-oer of tresh phosphate butter lacking CPZ. Thi. new 
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Table 11 
Uptake ot CPZ by VarIous TIssue Homogenate. In CoapetltloQ 
with eaoh other 
All tissue. were prepare. as 1:100 homogenates. Buttereel OPZ 
so~ution. pH 7.12. oonstitutod the outer chamber (8ee .ethoels). 
I '\ Cone 1n 9~O~Z (microgm/m1)* Tissue I ExperiJlent , 
Homogenate ! l)uratlon r OutEn" 1 edium ! Inner i InIt!a1 Pinal Oh.mber 
----,----·,----·f,----,,,>-··->,··-·,· ,.~-'",---,------"'«,".-.. ,., .. ,...,., r" 
Expt. 1 ! 6 325 197 t 1 I C Ell'e brUlll I 384 ~ 2 ! Heart 1 ,58 ± 2 I Liver , I 14 t 16 
Lung i 344 ~ 32 , I 
I I bpt. 2. I 6 3)6 ± 6 I 178 ± 4 Cerebrum 
1 
I 316 
Heart I .38!}. ! 6 Liver I 398 ± 2 
Lung I ! 362 ! 1.4 
..sxpt. 
.3 
, 
18 372 ! 6 I 168 ! I Cerebrum I I 451 ! 9 aeart I 1 462 Liver ! , S06 ± 26 Lung I ! 417! 5 ! i I I Expt. 4 18 372 + 6 172 + 1 
I 
- -OerebruDl 458 ± 21 
Heart 444 t 25 
I Expt. 5 20 336 ! 8 163 !' 3 I CerebrUJll I 40~ Heart I 39 * 1 Livex- 430 - 4 Lung 3.34 ! 14 
Expt. 6 20 .336 + 8 168 
-Cerebrum ~99 ;!; :5 Hear1l I 02 ± 5 Liver 
1 
410 ! J 
Lung 314 : 10 
*Figures include ave~age ± range (result. for 2 analyses 
per eaGh figure). 
-
~ 
, 
i 
~ 
i , 
i 
I 
i 
! 
I 
i 
I 
I 
I 
I 
i 
I 
I 
I 
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asselubly was dialyzed for another period (see table 12). Butter 
oontrol as.emblies, that is. the inner oompartments containing 
butfer solution only, were subjected to the same prooedure. The 
butter control showed the establishment ot a second aqul1ibrium 
following the initial upt9K8 experiment. This indicated that the 
dia17s18 bag was not damaged by the prooedure which· nUIlY' have re-
sultad ~n an interferenoe wi th the movement ot the CPZ outw8.Jtd 
from tbe bag. 
The results of tour experiments oon1itl1nlng oerebrum 
homogenatt18 are shown in table 12. From these assemblie. it was 
observed that the unbound OPZ, pre.ent in the physi.cal 8')lut10n 
ot tbe tissue homogenate, ~hioh constItuted the amount of OPZ in 
equilibrium with that ot th3 outer solution of the first assembl,. 
moved aoross the membrane of the dialysis bag to reelltabl:tsh an 
equilibrium. The remainder ot the OPZ wlthin the oonfines ot the 
tissue oompartment, that 1s, the bound CPZ (~abl. 12, oolumn D) 
.ust have eXhlbited an attinity to the tissue (Table 12, colurrltl 
H). Otherwise, slnoe a concentration gradient was evident, equal 
amount. of OPZ should have been found in the inner and outer 
solution or the second dialysis assemblies. The latter did not 
ooour (Table 12, compare oolumna F and G). 
Furthermore, when the inner oom.partment oomposed of a 
homogenate (ltlO) prepared from the cerebrum of a oat given aPZ 
in vivo was dialyzed agalnet phosph~te hurfer in tho outer oom-
partment. it was observed that th~ already bound CPZ was not 
r 
IDIALYSIS 
BAG DURATION 
ICONTENTS (HOURS) 
i (A) 
iCerebrum *** .. 
I 1:100 *** .. ! 
Cerebrum 6 
1:100 6 
Cerebrum 6 
1:100 6 
6 
Cerebrum 18 
1:100 
Buffer 6 
TABLE 12 
AFFINITY OF CEREBRUM HOMOGENATES FOR CPZ. 
OUTER SOLUTION VOLUMES OF BOTH ASSEMBLIES WERE 30.5 m1.; 
INNER HOMOGENATE VOLUMES WERE 10.0 m1. ROOM TEMPERATURE. pH 7.12 
INITIAL DIALYSIS SECOND DIALYSIS 
CPZ CONC'N. ()Jg/m1) CPZ CONC'N ()Jg/ml) i TOTAL AMTS 
*UPTAKE 
INNER *OUTER BOUND DURATION "'INNER flOUTER BOUND INNER 
CHAMBER CHAMBER CPZ (HOURS) CHAMBER CHAMBER CPZ CHAMBER 
(B) (C) (D) (E) (F) (G) (H) (J) 
358 
357 193 16 .. 16 172 60.6 111 1720 
3 ..... 5 231.5 113 
**362 235 127 16 176 61 115 1760 
3"5.5 205.8 HO 
**352.6 203 150 16 188 53.8 13 .. 1880 
**351.3 20 .. 1 .. 7 18 188 53.7 13 .. 1880 
** .. 08 169.7 238 6 257 "9.7 207 2570 
**230 23 .. 
--
16 53.3 52." 
* Each figure includes the average of two analysis for CPZ. 
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OF CPZ ()Jg) 
OUTER 
CHAMBER 
(K) 
18 .. 8 
1860 
16"1.1 
1638 
1512 
** These figures are estimated from analysis of inner and outer chambers of the second dialysis assembly. 
These figures multiplied by 10 (the total volume of the inner chamber) are equal to columns J plus K 
of the respective experiments. 
*** This experiment was terminated prior to equilibrium. 
r 
! 
~ , 
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r.le ••• d into tbe outer oompa.-.ent (!able 1). Thi. particular 
o.reb~u. oontatned pharmaoologioal 81gnltlo p nt nmounts .of r,PZ; 
that ls, 104 t1&lo1"oSIR. OPZ per gil •• Il. found to11ow1rlg the In'N-
•• noua injeotion ot CPZ (analysIs of the hn!'flogen'lte, 1110, pre-
pared t~ this tissu., Indicated 10.2 mlorogm. OPZ per ml ot 
ho~s.nate). This oerebrua w~s Alao o~pabl. or turther oonoen-
trat10n ot OPZ, in vitro (!able 13). The upt~e ot CFZ atter 
tVeat1-tour hour8 ot d1alY818 va. 791 miorog_. per al. It appear-
eel tbat the combinations tormed by onz and the tisaue 110" 
rather tirm. 
'1abl0 13 
Dlal,81. ot O.r.~rua fpo. cat 1Iblob bad b.en Administere4 
IntI-avenous apz 
out ••• 01ut1on "olu... woro )0.5 .1, lnne. 801utlon .01 .... 
ot homogenat •• , 1110, were 10.0 ale pH 7.12, roo. 'o~er.turo. 
souoo Dlall81. o.ter __ 041ulI QllZ Con.tn 
J)Uratloa content, Inlilal Inner 
(Boul'. ) Conoto 801u'io. (m.loresm (lIdcrcgm 
per al) p •• 81) 
,..-..... "'-----.. ,.-.~,~ "--_._---------_.- -
Ce .. br. 16 Butt ••• 4 CPZ. lsa 8)2 
"O.1".-'u. 24 SUtt ••• 4 OPZ 344 791 
*O.".wua , 24 BlItt •• 0 10.1 
*tal'.&1 CPZ oOllteDt 104 aUoroSa. per gil. hal,.81. of 
ti.sue homogenate, 10.2 .1oroa-. r.~ mI. 
CHAPTER V 
DISCUSSION 
SpeoifioitI ~ ~ ~ Method 
Recoveries ot OPZ ot almost 90 per oent were obtained 
by means ot the desoribed prooedure for the quantitative analr8is 
ot OPZ trom biologioal tissues based upon the extraction ot OPZ 
trom alkalinized ether and the subsequent oxidation ot CPZ br 
terrio ion in the presenoe of sulfurio acid. The advantages ot 
this prooedure were: 1) speotrophotometrio readings may be ob-
tained in the visible range, thereby eliminating the correotions 
tor tissue blanks whioh are required in the ultraviolet methods; 
2) reooveries of CPZ iro. animal tissues, espeoially brain, were 
greater than those previously reported ()9,48). 
The prooedure appeared speoifio for CPZ and other 2-
ohlorophenothiazine. possessing a side ohain on the ring nitrogen 
One point to be clarified 1s whether or not the material referred 
to in the RESULTS a. 2-chlorophenothiazine with a N10 ... ide ohain 
(2-C1N) __ y represent chlorpromazine itself, or include also the 
metabolites of CPZ. 
Metabolism ot OPZ haa not been tully clarified. Sulf-
oxide. (69); oompounds altered 1n the N10-alkyl ohain (70-72) and 
and N-oxlde of CPZ (7)); monophenols (14.75) and oonjugated mater 
lals (47,74,76) were identif1ed as metabolites ot CPZ. 
pounds represent, depending on spe.le., trom 22 to 35 per oent 
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ot administered CPZ (17,78). Relative!',- little OPZ is exoreted 
unohanged (77,78). the tate .r trom 60 to 80 pel" oentot OPZ is 
not known. 
!he method employed reveal., besIde. CPZ, obl~rlnate4 
phenothlazines diftering from OPZ 1n the N ohain, as well a8 
their sulfoxidea; 1t doe8 not asaay oompounds with major ohange. 
in the phenothiaz1ne ring, with substitution for ohlorine in the 
2 position, or with ohlorine preaent elaewhere In the ring. Thua, 
the asaay may have measured, bes1des OPZ, the metabolites de.orlb-
ed above and perhaps unidentlfied CPZ metabolites, provided they 
are olose analoga of OPZ. 
Slnce gluouronide oonjugation does not ooour in the oat 
(79,80), the presenoe ot CPZ-gluouronides in the.e analyse. 1. 
unlikely. Reduced pharmacolO;ioal aotlvity e:xblb1ted by some of 
the C?Z metabolites have been reported. The sultoxidation prod-
uct. ot OPZ exhib1ted deoreased pha~aoologioal activ1ty (81-84). 
BorlOPZ showed only slightly le.aer aotlv1t7 than OPZ, but the 
primary amine analog, lfor2CPZ, exhibited pharmaoologio aotion 
about equal to that of CPZ. OPZ-IO was found le88 effeo1;lve 
pharmacologioally than WorlcPZ (8).84). Sinoe ~.duoed pharmaco-
10g1c ettec's may be antioipated from aome of these derivative" 
there appear8 le88 likelihood for their presenoe. 
On the other hand. metabolite. generally do not rems.ln 
in the ti8SU.S tor long and they oan be expeoted to appear rapid-
ly in the blood. The faot that only low levels of 2-CPN were 
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found in the blood, suggests relative absenoe of such m.etabo-
11tes. Furthermore, there is no indication that CPZ 1s metabo-
lized in the brain, muscle, or lung. Altogether, it is likely 
that the 2-C1?N flguresr9ported here :tor blood, brain, musole or 
lung, reter mostly to CPZ. This ssems certainly true tor sbort 
t1me intervals after the administration or CPZ. Admittedly re-
sults reterring to liver may bear a different oonnotation, sinoe 
liver oonst.itut •• the .ajor sl'e of CPZ Jletabolis. ()9. a, .. 87). 
Tissue Dlstribution of CPZ 
--
It is interesting that the.e data indio ate ~apid tran.-
ter ot intravenously ad~lni8tered CPZ trom the blood to other 
tissue.. \..,lthln ten minutes the blood levels ot CPZ were con-
a1stently low and did not refleot the levels of the Qor~ound in 
other tissues. It should be stressed that immediately after In-
jeotion very high levels of 2-CP1.i were fOUl"ld in "the heart and in 
) 
the lung. However, this acoum.ulation WB,g only tempor~y, and 
subsequently heart and other muscle exhibited ~elat1vely low 
levels of 2-CPN. wldle 2-CPB ooncentrations in the lung levelled 
ott at a high plateau. 
Data on the oonoentration. ot GPZ 1n the brain atter in 
vivo administration vary extensively (39-43, 88-90). This va~1a­
tlon may be due to the fact that, as in the oa.e of the present 
•• thod, methods employed may not have been speoific for CPZ, even 
though the data were expres.ed 1n terms ot the latter. On the 
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()9), who used an ultraviolet speotrophotometrio method tor CPZ 
determinatlon in dogs# and with those ot Christensen and Wase 
(41), who employed S35 CPZ In mioe; both these groups reported 
aocumulatlon and oonoentration ot CPZ In the braln. 
On the other hand Fyodorov (40) who employed 53> OPZ 
In rabbits, rat. and dogs; W.ohaler and Rolzin (42)wbo used an 
ultrav101et speotrophotometrl0 method tor rats and. monkeys, and 
Y.luda and Aoki (43) uslng rat. and a speotrophotometrl0 techni. 
que, obtained low level. ot OPZ in the brain. In tact, Wechsler 
and Roizin (42) reported -'raoe." ot aPZ tollowing intramusoular 
administration ot 100 mlorogm. per gm. ot this compound to rats. 
Wechsler and her alsoolatea (42,48) suggested that the results ot 
Salzman and Brodie ()9) oan be explained by inadequate reG overy 
obtained by these investigatorsl this argument Gannot hold with 
regard to our results, .1noe OPZ vas quantltatively reoovere. 
trom the braln oy the pre.ent method. Furthermore, deJaramillo 
and Guth (88) tound reoover1 •• trom th. Weahller and Forrest 
method were about SO per cent trom the braln. 
Stlll another problem arls.1 with regard to distribution 
ot CPZ within the brain. Was. et &1. (89), using the radioisotope 
method reported great d1fterenoe. between OPZ oonoentration. in 
variou8 brain areaa, with the higheat levels found In the thalamua 
.t.er single administration. A JOO.told d1tter.noe was found 
between oonoentrations 1n the thalamus and tbe oortex, and a 3-
told differen.e between those in the thalamus and the aereb.llu •• 
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Guth and deJal'8lIlillo (90) reported in a pre11m1nary study th.' 
the levels of CPZ in the hy-pothalamus and in the lIled.ulla ot dogs 
were 7-10 times higher than those in the oerebellum. de Jaram1llo 
and Guth (88) also reported negligible amounts of CPZ in the tem-
poral and trontal oortex of dogs forty-five minutes following CPZ 
injeotion intravenously. However, Weohsler and Roisin (42) ad-
·f 
ministered 1$0 miorogm. per gm. ot OPZ to monkeys and found l1tt14 
ditterence in CPZ oonoentrations in the b •• al ganglia and in the 
oortex, and on17 traces ot OPZ in the cerebellum and pons. In 
the pre.ent study, no suob pronoun.ed differenoe. were tound be-
l tween CPZ oonoentrations in the brain stem, oerebrum, hippooam-
, ' 
l pus and oerebellum, although the brain stem and the hippooampus 
~. 
retained 2-aPlf (or CPZ) so.ewhat bettal' than the other part. ot 
the brain. 
A partioularly interesting faoet ot tbis study is that 
tissue levels at CPZ or 2-CPN were measured over a forty-e1ght 
hour period; thls 1s a longer t1 •• period than that covered by 
earlier investigat1ons. In several t1 •• uem 2-0PN was retained 
tor a long time. Atter .it aooumulated in the brain 4-$ told 1n 
one hour, ita level deoreased slow111 even at torty-eight boura 
it di~ not fall sign1fioantly below that oorl'8spondlng to the 
dose administered (40 rtUorogm. per gm.). Retention ot 2-CPN 1n 
tbe 11ver was even more pronounoed; moreover, the pattern of the 
disappeara.noe ot 2-CPH trom the 11ver was difterent trom that 
observed in the brain. Atter a higb level ot 2-CPN was maintained 
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in the liver for twelve hours after ita administration, it de-
creased subsequently. While Fyodorov (40) and Salzman and 
Brodie (39) also found high levels of CPZ in the liver, they re-
ported that liver CPZ content deareased rapidly in rabbits, rats, 
and dogs within tllr •• hours of its adUlinlstration. 
The third tissue whioh aOQu.ulated and stored CPZ (or 
2-CPN) WaS the lung. Tne lung differed fro. brain and liver by 
aooumulating 2-CPN 110ft extensiv.l,., and retaining It for a 
longer period. Ind •• d, in the lung. there was uo deol'ease in 
2-CPN oonoentration troll ita peak at three hours tll1 forty-eight 
hours atter ita administration. 
Altogether, oontrary to the earliest Investlgatlons, 
(39 .. 43) this studT indio"ted tha.t the 2-CPN oonoentrations do not 
d •• rea •• uniforml,. in all tis.u... Any tlssue, th.r~fore, might 
exhibit the highe.t CPZ or 2-CPN oonoentration at anysp.aifio 
ti ••• 
Ho explanation tor tbe ••• hifts aan be given at pre.ent. 
liDoe the liver 1a imp11cated iD the metabo11sm of CPZ by 1D 
vi'PO Studi8. (4.7, 8S-81) it lIl8.7 be speculated that CPZ IIetabo-
lia. may be induoed in the liver after a latent period. Another 
tattor may be the releas8 ot CPZ or 2-CPN trom variou. ti.sues. 
and 1t •• torage in fat, where it. level is high in one and two 
hours. However, fat doe. not s.em as important ~; .torage s1te 
tor CPZ as for thiopental and pentooaroi.al ($0-$2, 91). 
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Oorrelate. !! Pharmaoolof~o Ao'lyltl and Brain ~ Level. 
An attempt was made In .. the cour.8 of this stuciy to 
oorrelate the ohar.ges in oonoentI"'a.tions ot 2-0PN in brain wbltb. 
occur with t1me with the intenslty or the pharmaoologic aotion 
,ot CPZ. It should be stressed, first of all, that the levels ot 
CPZ In whole blood could not be used to prellliot the pharmacologic 
.otlons of thls compound slnoe blood oonoentrations remained low' 
and relatively oonstan'; trOll seven minutes to forty-eight hours 
atter the administration of CPZ. The temperatures ot OPZ-treated 
oats rose above those of restrained oontrols after twenty-four '0 
thirty-two hours, while oerebI"'um oonoentrations ot 2-CPN deoreas-
ed to about 60 mlorogm. per gm., and thus was two or three tim.s 
lower than the peak level. At that t1.e the analges10 aotion or 
CPZ, ascribed to the depre •• lon of the mldbrain retioular fo~a­
tion (92). was stl11 evldent, but the righting reflex had largel,. 
reoovered. Th. analge.ic etreat of CPZ, tranquilizat10n, and 
anorexia perslsted even when the level ot 2-CPN in the oerebrua 
decreaaed to 30 miorogm. per gm. This,· too, suggests that .eaa-
urements ot 2-CPN in t~e braiD actually reter to OPZ itaelt, or 
less 'probably, to an equipotent, unidentified, metabolite ot CPZ. 
Thus, not All neuropharmaoologic a.otions of OPZ are terminated 
simultaneously. This could be explained if not all brain parts 
lost OPZ--or 2-0PN--equally rap1dly; it m~7 be suggeated th.' 
tranqul11zatlon at rorty-eight hours depends upon relatively 
high 1eve18 ot OPZ at that time in the braln ate. and the hippo-
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.ampUI, sinoe the latter Was associated with emotional behavior 
(9). !his sugge.tion i8 all the more speculative since the be-
havioral significanoe ot'various brain areaS is stl11 obsoure. 
Interaotion ~ ~ ~~ Tissu! Homogenates 
Interaction of CPZ with hornosenates of different tis-
sues was observed by means of the equilibrium dialysis technique 
utIlIzing a phosphate butfer system. The preterential uptake 
shown by the tissues in the Intaot animal was not evident by 
equilibrium dialysis in the bufter sY8tem employed. Homogenate. 
of eaoh tissue, oerebrum, heart, li.er, and lung, prepared in 
dilutions ot 1 gll'l. wet weight tissue per 100 ml exhibited res-
peotively similar uptake. at equilibrium ot about 400 microgm. 
CPZ per ml ot homogenate. Approximately 225 miorogm. ot this 
CPZ or 55 per •• nt vas bound to the ti.sue. 
Bmpl,ying oerebrum h~mogenate as a representative ot 
the.e tisaues, an inoreas8 ot the homogenate oonoentration to 
1110 refleoted in a greater uptake or CPZ by the tissue to more 
than 800 mlorogm. CPZ per ml ot homogenate at equilibrium. ot 
this OPZ uptake, almoat 700 miorogm. or 87 per oent was bou~d 
CPZ. Whether 1:10 or 1:100 homogenate. were used during equili-
brium dial~sls, the bound CPZ tar exoeeded the oonoentration. ot 
cpz round in the animal tissues in vivo. 
It was observed from the oompeti tion ex;)eriments, that 
is, those experiments in whioh single dialysis aS3embl!es con-
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thav eaoh of these tissues, cerebrum, heart, liver, and lung, 
exhibited essentially sill11ar uptakes ot CPZ and thus, .each tis-
sue displayed similar blnding ot OPZ. These experiments provided 
support that the d1tteren'llal uptake ot the tissues in v1vo was 
not evident by the technique employed in vitro. 
Since similar uptake and binding of CPZ by equilibrium 
di&17S1s in the phosphate butfer system were exhibited by the 
tour tissue., cerebrum was .eleoted as a representative tissue 
to investigate some oharaoteristios ot tbiB system tor the CPZ 
interaotion with tissue homogenates. Var,.ing ttl.e initial CPZ 
concentration ot the outer ohkmber trom 0.1 to 1.0 roM resulted in 
a linear increase of the uptake of the CPZ by the oerebrum homog-
enate. (1;100). The 1 mM CPZ conoentration did not appear to be 
at the limiting level tor the OPE uptake. Neglig1ble eftectlJ b,. 
telllPerature ohanges were obseMed on the equilibl-iUDl level of CPZ 
uptake b~ the cerebrum homogenates (l:lOO)--simil~ uptake. were 
exhibited. at 0-4 0 0 and 24-26 0 0 j although tbe lower temperature 
prolonged the period to attain equIlibrium, Goeurring at about 
eight hours as compared to six hours. at room temperature. Heat ... 
ing the tissue homogenate at 90 0 C for two hoUl's or the ageing of 
the homogenate also showed no sign1fioant va:t"iatlons of the up-
take or the amount of bound CPZ at equilibrium. 
Tbe combination of CPZ wlth the tissue homogenate ap-
peared f1rm. Transter of the dialys1s bag to another assemb11 
atter an uptake of OPZ in the first dialys1s .. sse_bly was 
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e.tablished, or the performanoe ot the dialY8is experiment upon 
oerebrum homogenates prepared trom an animal adainistere4 OPZ, 
resulted in very little losa ot the bound OPZ (See results seo-
tion 'l'able 12, oompare columns D and H; also 'l'able 13). 1'bu •• 
oerebrum exhibited a rather stl'ong atfinity tor the bouad CPZ. 
Kany factors may have c0ntr1buted to the difference ot 
tbe result. obtai~ed in vitr-o as compared to the preferential 
uptake ot CPZ exhibited by the tissue 1n vivo. Firstly, the 
blood tl~w to the various organa investigated dltfers markedly 
(94.95). Blood flows through the heart and lungs and then the 
blood is distr1buted 1n var10us peroentages to the organs. In 
Dorll8.1 human sub jeota at rest the blood flow has been e8 t11ua ted 
(94) in pel' oent ot oardiao output as tollowB: cerebral, 13. 
001"0119.1'1'. lh BpIaooh1l10, 24, and. renal, 19. Estimates a .. ailable 
tor the deg (95) Indloate that the blood flow to the heart, liver, 
and kidneys ln peroentage of oard1ao output was 5.2, 10.0, and 
11.1, respeatively. Thus, ditferent amounts ot OPZ are delivered, 
in unit tl .. , to each tiasue. During equilibrium dialysis, the 
extePDal medium ot the phosphate butter exposed the same amount 
ot OPZ to each of the tissue homogenates. 
Secondly, aome structural oompon~nts or the oellular 
oompartmentalization which mil:,. be responsible tor the ditferen-
tial uptake and the binding of OPZ in the tiasuEt in vivo ma'1 have 
been destroyed durlng Ule homocienizatioll procedure. The preae1l0e 
ot a blood brain barrier (96) or other membranes (91) haa been 
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lnyolv.d in the mov.men1 ot drugs into and out ot an organ. 
Preeman and Sprite. (98) have shown that human erytbroQytes can 
co_bine w1th OPZ and they have attr1buted CPZ ette.1s to alter-
atlons ot membrane permeabllity. Perhaps these alterations play 
a role, in vivo, preventing the ru~her influx or outflow of CPZ; 
the membranes are d1szoupted during the hOltlogenlzatlon prooedure 
and tbus do not partioipate in nertlnent prooesses. In the ab-
sen •• ot these alements various biochemioally identified, or as 
".t unidentlfied, urll ts ot the 0.11 present 1n the homc.genate 
aay then bind indisorimlnantly with OPZ. 
Several oe1lular substances or components nave been 
reported as capable of interaotion with OPZ, in vltro (96.10). 
Barris, Saiter and Volk (100) reported CPZ bound slgnifioantly to 
tbe .ganglioside strandln. a.nd also to ohrondroitln sulfurio aoid 
and hepa~ln. Yagl at ale (101) reported ~ oomplex formation ba-
tween CPZ. at a Qono~ntrntlon of 10-3 M, and the isoalloxazine 
oompon.ant ot flavins. Dingell at ale (102) reported tha.t OPZ was 
boullc1 primarily to the partioulate matter of cells. Mitoohondria 
ls01ated fro. brain were found to exhibit greater aftlnit7 than 
11 Vel' m11;oohondrla for OPZ (10.3). The type 0: oOlnbinatlon ot 
CPZ with a cellular oonstltuent appeared to be ~irm. The results 
obtained from these experl~nts indicated that the tisau.s had a 
8tron~ affinity tor CPZ. In the absence ot the struotural OOM-
ponent!! and differential blood flow present in vivo the cellular 
oo.ponenta ma7 be capable of interact1ng ill vitro to a difterent 
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extent than tha~ .e.n in vivo. 
Bhrenprela (99) had reported that OPZ exhibited binding 
capabilltie. to the protein he Is01ated by fractionation with 
a_onlum sulfate and whioh at first (61) was oonsidered .a a 
"receptor" for acetyloholine but later (104) as the "drug binding 
oomponent ot oonducting membrane only". Hiatochell1oal resul'. 
obtaiaed hy Ehrenpreis (104) indioated that the !lreoeptor" pro-
tein was present in oloae proximity to, or a part ot, the "111~ 
brane. He suggests the possibility tbat this protein may be of 
.embranous origin. Spirtes an~ ooworkers (98, 105-107) have also 
implied tbat CPZ ett •• ts were related to alterations ot membraD. 
perlleability. The looation of CPZ aotivity on the BlEuerane may 
be related to the faot that .ell membrane. are Gompoaed primarily 
of lipid, that ls, phospholtpid. 
Some physical and ohemical Gharaoteristi •• described b7 
BbPenprei, (104) for the drug-binding protein were that it did 
not gel on heating and that it contained a significant amount of 
phospholipid. In the equilibrium dialysis experiments reported 
at pre.ent, brain hOMOgenate. h.ated in phosphate but~er at pH 
7.1 s1'1owed no apparent alterat;ians of the binding ot CPZ. Per-
hap.s the oellular struoture described by Ehrenpreis may be impll-
oated 1n the binding of CPZ in the pre.ent experl •• nts. 
So.e conalderatlon may also be gIven that OPZ, a lipo-
philic compound, may have become bound to the lipoprotein, or to 
the sphlngo11plda, tor example, the oerebroside. or gangliosid ••• 
Oere~ro.id.8 and aangllo.ide. ooour in tl •• ue. otber tban in 
Drain. The gangliosidel have been found in mo.t parenohymatou. 
ti.luea, tor example, .pleen and erythrooyte.. However, the ti.-
lue. fnye.tigated ezh1b1t ditterent ganglio.14e Gonoentration.; 
OR the baaia ot phosphorus per 100 sm. freah ti •• ue, rat liy.r 
oontain_d on.-halt the ... ount of sphingomyelin round In rat heart 
and about one-thlrthieth that ot cat hrain (108). Theretore, 1t 
1. unlikely that the bindilll .rteat. in vitro _., be attrihuted 
aolel,. to the bind1ng to ganglioside •• 
-An explanation ottered by Harri. et &1. (100) tor the 
signitloant bindi~g of CPZ to st~andin# a rather apeoiti. gangli-
.aide trom the brain, was that the reaction ooourred between the 
oerbolt,.l group of the neuramin10 Acid in the ganglio.ide and tb.e 
overall pos1t1ve oharge of CPZ. The v1ew that N-aoetyl neura-
mlnl0 aold ma7 be involved in the role of the ganglio.idle bind-
1ng of CPZ i. po.aibly supported by the work reporteel by Irwin 
et al. (109). 'lhe.e inYeatigator. found that ganglioside. pre-
vented the bloeklng activity of CPZ on aoetyloholine stimulated 
trog reotu. mUlol.. Partial destruotion of 1Ihe ganglios1de ao-
tlvit7 against tbe OPZ aotion o •• urred when .·ao.tylneuraainio 
ao14 waa removed by aoid hydrolysis trom tbe ganglioaiele. 
When the role ot auoopoll.aoohar1de.t tor ex .. pl •• 
'byaluroni. aolel, b.epariD, and the ohondroltlQ sultate., wbioh 
oonstltute intesra1 components ot the muooproteins, 1. eluoielated. 
perbaps tbe Ind180riminate bindlng exhibited by tbe ti.sue. in 
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vitro .ay be olarified. Ohondroitin sulfate has been found pre. 
sent in the heart valves, the skin, the cartiage, tendons and 
bones. Heparin is also present in various aniJU.l tissuea (110). 
The homogenizati~n procedure may release these sUDstanoes trom 
oertain toroes existing 1n vivo whioh exert a ditterentiating 
ettect tor tbe oombination of CPZ with thqt particular organ. 
'lb. results obtained with blood in vitro could pos8ibl,. 
b. extrapolated with the results obtained in vivo. Uptake and 
binding ot CPZ by blood, when whole blood (lrlO) oonstituted the 
inner oompartment during eq u:11ibrlultl dia1ys1a, was lIuoh leas than 
tbat exhibited by comparative amounts of the other tissues. Thus, 
the low uptake of CPZ by blood in vibro may b. considered as 
favorably oomparing witb that found In vivo. 
However, when undiluted blood oontalning CPZ oonatltn-
ted the outer compartment whioh WIiS used against tissue hOMogen-
ate •• s the inner ohamber~ very little OPZ penetrated the d1a1181. 
bas-·that 1s, not even the equilibr1um ooncentration in the 1nne~ 
oompartments was atta1n&d. Thi. is unlike the findings in vivo, 
In whioh tbe tissues displayed a rapid uptake of CPZ trom the 
blood. CPZ may bave be.n, bowever, preoipitated by the blood and 
th1s would prevent dialys1s of CPZ from the outer to Inner oham-
bel'. OPZ, at 10-3 H, was preoipitated 1n phosphate butter at pH 
7.4--tbe approxImate normal pH of blood. The white crystalline 
preoipitation ot CPZ was not observed in the blood, in vitro. 
At tbe termination of the experiment the blood had a pH of 7.2--
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a pH at which CPZ i. soluble. Fupthermore, OPZ has a pKa ot 
8.2 (111). Thus, even at pH 1.4 enough CPZ should have. b.en 
ionlzed to ettect an inward migration to the binding slte. ot tbe 
ti.su.a. 
It 1s conceivable tben that the whole blood, in vltro, 
oould b1nd the CPZ, 1t CPZ were presented to 1t tirst, and if tb. 
t&otors pre.ent 1n vl"o, whioh induce the release or OPZ tro. the 
blood to tbe tis.ue., were not actl"e in v1tro. In v1vo, blood 
was capable of Inlt1ally ooncentratlng approximatelT 300 microgm. 
CPZ per III (Ie. Pig. 10, Results), e"en though tor a short dura-
tion. 
Also, it sbould. be remembered that 1n v1tro, undiluted 
whole blood oontaining CPZ was dialyzed aga1nat ti.su •• at lslOO 
dllutlon. This tia.ue conoentratlon ditterenoe maT in Itselt 
aooount for tbe failure of the blood to rel.as. CPZ 1n vitro and 
may be a faotor which could be reoonoiled by oomparing blood con-
oentration versus tis.ue ooncetration in v1vo. 
The blood u.ed in th •• e experIments contained heparin 
whioh had been added to prevent Ita coagulation. Tbe binding ot 
OPZ by heparin haa been reporied by Harri8 e' a1. (100). Perhaps 
the pre.enoe ot heparin Ilay explain 80 •• ot the etteot. toward 
the uptake and blnding ot CPZ by the blood ln vltro. How.ver, a 
oonolusive interpretation of the heparin ette.t on the blood-CPZ 
lnteraotloR 1s preoluded by the influenoe whioh may be exerted by 
the tollowing obse'rva.tions: ,; 
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Firstly, the gradual los. of antiooagulant and an~l­
oomplementary aotivitie. of heparin inaubated with a washed red 
blood oell auspenaion was considered as indioativ. ot a disappear-
anoe and possible absorption of heparin (112). Thus, the binding 
of CPZ observed in the.e experiments with the blood may not have 
b •• n influenoed by the presenoe ot heparin. 
Seoondly, heparin 1s normally found in varying ~onoen­
trations in the liver, lung, spleen, musole, heart, and other 
tissue, expeoially the mast oells (110). The destruotion of the 
.ast •• 11 by CPZ reported by LeBlano (113) aay oause the release 
ot a rioh supply ot heparin. But, homogenate. ot liver- and lung, 
both known to 00nta1n large amounts ot hepar1n (110), exbibited 
sim11ar uptake and per oent bound CPZ as that obtained by the 
other tissues t"bIob <lontain lesser amounts of heparin. This con-
siderat10n tends to minimize the influenoe that the endogenously 
preduoed heparin mal bave had toward the etfect ot tbe bIndIng ot 
OPZ by the blood or the tissue. 
Thirdly. al'bough under nO!'l11al oondit10n., heparin i. 
not in the free state in the body, 1t is known that tree heparin 
lIay appear In 80.e abnormal oondi tiona. Dogs in anaphyla.otl0 
shook oan relea •• heparin troll the liver (110). The withdrawal 
of tbe lapge volume (about 110 ml) ot blood troa the ~at, a sm~ll 
animal. produoed •• vereshook. Oonoeivably, heparin 11U",. have 
been relea.ed trom the liver ot the oat so .s to attain a signifi-
oantly high tl ter in the blood. Tl.e le"el. ot tbe endogenously 
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proc!uoed heparin plua that added to prevent the coagulation ot 
tbe blood -1 bave been signiticantly high 80 that the binding ot 
OPZ bJ tbe blood may be at~ributed to the presenoe 01' heparin in 
these experimenta. 
Further Intere.t in binding etteots 01' CPZ with heparin 
oould posaibly oenter on the gluouronl0 aoid or other aold mole-
tiea present in beparin. Slnoe in theae experimenta, bornogenatea, 
and not purif1ed blooheminally Ind.nt1t1ed oonstltuenta were em-
ployed, perh~pa an explanation tor the lndisoriDd.nate In vitro 
blnding ob.erved here may be due to the aotion of carboxyl groups 
ot various compounds auoh as the B-aoetylneuramio aOid, and the 
glueuronio acids of hepa.rin , hyaluron10 a.o.1d and the ohondroi tin 
sulfate. whioh may oombiQ$ with the overall po.itive oharge ot 
OPZJ the.e groups may be indiscriminately distributed in all tis-
sue. studied. 
Another cODsideration pertaining to tha in v1tro study 
ot blood is that CPZ oan, in vltro, combine with the red blood 
.ell. and alter the oamotio permeability of the erythrooytl0 me~ 
brane (98). Perhapa, onoe the red blood .ella have taken up CPZ, 
the al tered osmotio parmaabilit,. prevented the relea.se of OPZ to 
the tissue hOMogenate8. 'l'n. explanation ot t;he binding of OPZ by 
the erythrooytes in :vitro .erit further investigation. 
Thua, many questions are presented troll the results ob-
tained, in vltro. It is iYlteresting to attempt to identity tbe 
oomponent or components that exist in vitro and in vivo whioh 
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bind CPZ. Extension ot results obtained trom equilibrium dialy-
sis upon purified proteins isolated from the tissue could pro-
vide information to oaloulate the energy ot association ot each 
ion a~ well as the number ot sitee available tor the binding ot 
the ion. Approaches through the Gombination ot CPZ with purified 
8ub8t~~C.8 hay. been reported (100). The attempt to isolate the 
OPZ-.. reoeptor by fraotionation of the C'PZ bound tilsue presents 
Many difficulties, perhaps the most important Is that through 
means of ohemical differentiation the CPZ may separate tl'OIl its 
tteoeptor oomponent. Some prellmina.ry experiments have been at-
tempted in this dipeotlan. 
OHAPTER VI 
SUMMARY 
1. A speotrophotometrl0 prooedure tor tbe quantltatlve 
analy.l. ot CPZ trOB biologl0 ti •• ue. baaed upon the extractioD 
or CPZ lnto alkaline ether and sub.equent oxidation by terrl0 10n 
1. the pre.enoe ot oODGentrated .ulfuriG aold 1. de.orlbed. Re-
Goverle. ot OPZ tro. brain by .ean. ot thl. method amount_d. in 
v1tro, to 86.6 i 6.6 per .eat. 
2. The pro.edure was apeoltlo tor apz and other 2-
oblorophenothiaz1ne. posseaalDI a side ohain OD the riD8 nltrosen 
Ohan,e. ia the phenothiazine nuoleus or sub.titution. tor ohlop-
lne in posltlon 2 pesulted 1n oolors whiob differed fro. the 
oherry-red ohromophol"e. Speotl"a tor un,- of thes_ oompouad. were 
e.'abli.hed. Thus, beslde. CPZ, other related oompound. oan be 
8.Qu.,sed ln ti.aues 1ry mean. at th.l. .."hod .... 
J. Tlssue levels of CPZ tollowinS lts intravenoua 
1nJeot10n lnto oat. were determined by this •• thod. Immediate1., 
following the adaini.tratioD ot CPI, 40 microgm. per gm., level. 
near 1 ag. per gmt Gould be determined in tbe heart and in the 
luns. There was a rap1d sh1tt ot OPZ tro. the blood to other 
tlslue •• 
4. CPZ oonoentrated to~r or five told ln the lung, 
l1ver, and brain at one hour atter It. adminIstration, at whioh 
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ti .. the content ot the heart and other tissues was relativel, 
low. GPZ content re.lned high in the 11 Vel" and in the. lung 
tor tw.lve and forty-elght hours respeotively. 
S. Pharmaoological aot10ns ot ohlorpromazine d1d not 
terminate simultaneously. H1Po'her~a and analgesla seemed as-
soclated with the )O-sO microgm. per 8m. CPZ levels in various 
parts ot the bl"ainJ tranqulllzat10n appeared to l"eQ.uire lesa 
CPZ. 
6. utilIzing equilibriuDl dialysia, the 1nteraotlon ot 
CPZ with the various tissue homogenate. ooourred in a phosphate 
butter s7atea·.. !he preferential uptake tor OPZ exhibited by the 
tissu •• in vivo was not eV1dent in vitro, and dialysia ot the 
tour tlssue. 1n single aas8m'118. did not show oompetitlon tor 
CPZ uptake. 
7. Cerebrum homogenates eXhiblted a stroug attinitr 
tor the CPZ. .egligible amounts of the bound CPZ wer8 released 
tram the tissue. when cerebrum homogenate. oonta1nlng CPZ were 
dialy ••• against phosphate butter. 
6. A dl.oullion of the various struotural oomponents 
, 
to whlch OPZ may bind was presented. 
APPENDIX I 
'reparation of Phosphate Buffer Solutions lJa'.ld. tor the 
Bquilibrium Dialysis Experiments 
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stock solutions of tbe sodium monohydrogen phosphate! 
(Wa2BPOh) and potasslum d1bydrogen pbosphate (KB~P04J 
pr~~~rea as de.crlbed In tbe t3Y.t were mixsd In ~. 
proportlc~s indloated below. Th pH ot the resulting 
801ut10n was checked on the Beckman Zeroaatic pH meter. 
lafHP04 KH2P04 pH 
111) (Ill) 
I 9.00 1.00 7.648 
8.00 2.00 7.347 
7.00 ).00 7.146 
6.00 4.00 6.976 
5.00 5.00 6.813 
!his table 1s III port1on of tbat found 1n Gortner, R.A. 
and Gortner, W.A.. Out11ne. ot Bioobemistry, )rd Ed., 
John Wiley & 30ftS, Inc., New York, 1949. 
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APPENDIX II 
!he dirtepenc •• , top all time periods investigated, b.lw.en the 
oerebrum and the oerebellum, and between various bra1n stem are.s 
and the hippooampus on on& hand, and the oerebellum on tbe other, 
were round signifioant at p > 0.05 level. 
(1) 
(2) 
() 
(4) 
(5) 
(6 ) 
(1) 
(8) 
(9) 
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